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South Africa has a shortage of workers in the healthcare sector, and this short-
age extends into anesthesiology as well. With this need, it would be helpful
to introduce a system that administers anesthesia automatically to lighten the
load on anesthesiologists as well as to help distribute available anesthesiologists
more evenly across the South African population. Therefore, a closed-loop
control system maintaining a patient’s depth of anesthesia was designed.
The system designed consists of an intra-ear electrode and monitor, reading
mid-latency auditory evoked potentials (MLAEP) from a patient, a control
system and an infusion pump to infuse anesthetic to a patient. The focus of
this study will be the design of the closed-loop control system interfacing the
intra-ear monitoring system and the infusion of anesthetic.
The closed-loop control system will have a reference MLAEP latency or
plasma concentration that it will need to follow, and the intra-ear monitor will
send the latencies read from the patient. These will be the inputs to the control
system’s model predictive controller (MPC), which incorporates a model of the
patient within the controller so that the infusion regime it determines is based
on patient-specific parameters. Once the amount of infusion is determined,
the system will send infusion instructions to the infusion pump to administer
the correct amount of anesthetic to the patient.
The designed control system was simulated, and its performance was com-
pared to a simulated closed-loop control system based on a PID controller.
This controller shows overall better control because of the shorter settling




the measured output that the MPC control loop achieves. The effect of mea-
surement noise on MPC control system was also investigated and the results
showed that the system was able to operate adequately with signal-to-noise
ratio (SNR) down to 15 dB.
From the simulations conducted, it was shown that the closed-loop control
system could keep a simulated patient adequately sedated using the MLAEP
as an adequate control signal to keep the patient sedated.
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Die tekort aan gesondheidswerkers in Suid-Afrika sluit ook narkotiseurs in. ’n
Stelsel wat narkose outomaties kan toedien sal die werklas van narkotiseurs
verminder asook help om die dienste wat narkotiseurs aanbied, meer eweredig
oor die Suid-Afrikaanse populasie te versprei. Met hierdie as agtergrond en
motivering is die ontwerp van die geslote-lus-beheerstelsel vir die instandhou-
ding van die narkosediepte by pasiënte uitgevoer.
Die stelselontwerp bestaan uit ’n intra-oorkanaal elektrode wat die MLAEP
(Middle Latency Auditory Evoked Potentials) van die pasiënt monitor, ’n kon-
trolesisteem asook ’n narkose infusiepomp wat aan die pasiënt se veneuse sis-
teem gekoppel is. Die fokus van hierdie navorsing was gemik op die ontwerp
van ’n geslotelus sisteem tussen die intra-oorkanaal moniteringsisteem en die
infusiepomp narkose.
Die beheerstelsel monitor die MLAEP sein in pasiënte, en bepaal dan die
pasiënte se plasma narkosekonsentrasie waardeur effektiewe sedasie gedurende
die instandhoudingsfase van die narkose bewerkstellig kan word. Die beheer-
der maak gebruik van die sogenaamde MPC (Model Predictive Control) wat
’n model van die pasiënt insluit en dus die infusie algoritme, gebaseer op die
pasiënt se spesifieke liggaamsparameters, insluit. Sodra die infusietempo be-
paal is, word die instruksie na die infusiepomp gestuur waardeur die korrekte
narkose aan die pasiënt toegedien word.
Die stelsel ontwerp is met ’n geslote-lus-sisteem, wat ’n PID (Proportional-
Integral-Derivative) beheerder insluit, vergelyk en gevolglik ’n beter beheer




lus bereik kan word tot gevolg het. Die stelsel-ontwerp het ook die effek van
metingsgeruis op die stelsel evalueer en kan bevestig dat die stelsel gemaklik
binne die 15 dB geruisvlak kon funksioneer. ’n Bykomstige ontwerp om die
narkotiseur in staat te stel om die diepte van narkose te beheer, is suksesvol
deur die stelsel gedemonstreer.
Die simulasieresulate kon aantoon dat die geslotelus beheersisteem die pa-
siënt effektief gesedeerd hou. Verder het die simulasie getoon dat die MLAEP
’n voldoende beheersein verteenwoordig en dus die gesimuleerde pasiënt oor ’n
wye spektrum suksesvol kon sedeer.
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South Africa has a shortage of workers in the healthcare sector, and this short-
age extends into anesthesiology as well [1]. With this shortage, it would be
helpful to introduce a system that assists in the administration of anesthesia
to help bridge the gap in the shortage of skilled anesthesiologists. This sys-
tem would need to operate without the need for constant supervision from
an anesthesiologist, and therefore, it would need to be able to provide the
desired anesthetic to a patient at reliable, safe quantities without the risk of
under-dosing and overdosing. The system would also need to be able to oper-
ate effectively with a wide range of patients despite the possibility of a wide
window of inter-patient variability.
1.2 Background information
Anesthesia is the controlled loss of sensation and/or consciousness in a med-
ically controlled setting. There are three types: local, regional and general
anesthesia. Local anesthesia is the loss of sensation in a specific, smaller area
of the body, for example the right hand; and regional anesthesia is the loss
of sensation to a large area in the patient’s body, for example the right arm.
General anesthesia is the loss of both consciousness and sensation. Anesthesia
can involve analgesia, the loss of pain sensation; paralysis, the loss of muscle
functionality; amnesia, the loss of memory; or unconsciousness [2].
Anesthesiologists have a great responsibility in sedating and maintaining
the comfort of a patient in surgery by administering enough drug to keep the
patient from experiencing the pain or stress of surgical stimulation while mak-
ing sure the drugs administered cooperate with the patient’s pharmacological
requirements. Under-dosing of the drugs could lead to intraoperative aware-
ness that could cause postoperative post-traumatic stress disorders [3] while
1
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overdosing could be fatal as anesthetics can block the central nervous system
from sending and receiving information needed for normal bodily functions,
like breathing and maintaining a normal cardiac rhythm [3].
The skills shortage in anesthesiology could be attributed to the loss of ex-
perienced practitioners in rural areas, high personnel turnover and inadequate
training in anesthesiology. The automation of anesthesia could provide a great
benefit in hospitals that lack the presence of professional anesthesiologists [4].
To address the shortage of skilled anesthesiologists available, a system de-
livering anesthetic to a patient autonomously needs to operate for the duration
of a surgery without the constant need for human intervention. It will be best
if the system operated as a closed-loop control system. A control system is a
system that governs the behaviour of a defined variable. It controls the vari-
able by either keeping it constant in the face of external disturbances, or it
changes its outputs in order to satisfy a specified set-point [5].
It would be beneficial to implement a closed-loop control system to auto-
mate the delivery of an anesthetic. The controller would read signals from a
patient through some sort of monitoring apparatus, such as an electrode and
signal acquisition, into the control system and the control system would be
responsible to determine how much anesthetic to administer based on the cur-
rent readings. It would also be beneficial if the system incorporated a model of
the patient receiving the infusion so the system can base its infusion algorithm
on the patient receiving the infusion.
Monitoring the depth of anesthesia that a patient is experiencing would re-
quire analysing one of the various electroencephalogram (EEG)-derived signals
that are available, like the Bispectral Index Scale (BIS) [6] and the Auditory
Evoked Potentials (AEPs) [7], and there are various monitors available to mon-
itor these signals [8]. Mid-latency Auditory Evoked Potentials (MLAEPs) are
signals derived from EEG signals generated as the brain responds to an audio
stimulus. These signals have shown to decrease in the speed of their response
based on the depth of anesthesia experienced by a patient [9].
In [10], a novel intra-ear monitor has been developed to track the MLAEP
of a patient during anesthesia. Using this latency acquired from the monitor,
a closed-loop control system delivering anesthetic drug and incorporating the
pharmacokinetic and pharmacodynamics of the patient [11] can be designed
to autonomously control the depth of anesthesia experienced by a patient.
1.3 Significance and motivation
Automating anesthesia could assist the available anesthesiologists by providing
consistent, accurate dosages of anesthetic to the patients, potentially requiring
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less oversight. The system could also immediately alert the anesthesiologist if
a problem is detected either in the patient or with the infusion system. [1].
According to the South African Society of Anesthesiologists [1], anesthe-
siologists are responsible for overseeing one anesthetic procedure at a time.
Automating anesthesia could allow the anesthesiologist to be able to oversee
more than one procedure at a time from a control room. The system would
maintain the patients in a state of anesthesia and alert the anaesthesiologist
in the case that an intervention is needed.
1.4 Contributions
Firstly, this thesis highlights that a non-invasive intra-ear monitor can be used
to estimate a patient’s propofol plasma concentration by correlating the con-
centration with the latencies of the MLAEP signals generated as the patient
experiences deeper levels of anesthesia. This correlation is achieved through
plasma concentration to MLAEP latency modelling.
The thesis shows the benefit of incorporating a patient model into the con-
trol system. It also shows that the MLAEP latencies, or plasma concentrations,
are adequate control variables that can be used in a closed-loop feedback con-
troller administering anesthetic to a sedated patient through simulation-based
evaluation of an MPC controller with an integrated patient model.
Additionally, this thesis provides a simulation-based comparison of a PID-
controlled closed-loop system and an MPC-controlled closed-loop control sys-
tem, intended for automated delivery of anesthetic.
1.5 Research questions
Upon understanding the background of the problem, one can determine re-
search questions with the intention of answering them during the investigative
procedure. The research questions include:
• Can a closed-loop feedback control system be designed to interface the
intra-ear canal monitor and general anesthesia and what type of control
system would be suitable for use in automating anesthesia?
• How effective are MLAEP latencies as a control signals for use in closed-
loop control?
• How would such a system operate with the wide variety of patients which
exist?
Stellenbosch University https://scholar.sun.ac.za
CHAPTER 1. INTRODUCTION 4
• Is such a system capable of handling the requirements that an anesthe-
siologist would need to meet to keep a patient adequately sedated under
various conditions?
1.6 Assumptions, definitions and limitations
In the field of anesthesiology, the anesthesiologist, also referred to as an anes-
thetist, is the practitioner administering the anesthetic to sedate the patient.
The anesthesiologist relies heavily on a thorough understanding of pharma-
cokinetics and pharmacodynamics of a patient, which define how a drug moves
through the patient’s body as well as the effect that the drug has on the pa-
tient’s brain.
To automate the delivery of anesthesia safely and reliably, it would be valu-
able to have the closed-loop control system incorporating some information
about the patient for improved control [12]. Therefore, it would be advan-
tageous to incorporate a patient model into the control system to optimize
the anesthetic delivery to the patient, based on the knowledge of the drug
dynamics in the patient [12].
Another factor to be considered is that the system needs to accommodate a
wide variety of patients. This can cause the controller performance to decrease
because the same type and quantity of anesthetic drug could affect various
patients in different ways [13]–[15].
Finally, a potential concern to be considered is if the automation of anes-
thesia will be accepted by anesthesiologists and other health care practitioners.
Although the goal of the system is not to replace the job of the anesthesiologist
but rather to automate the task of maintaining the patient in a state of anes-
thesia [16], such a system could be seen as a threat to anesthesiologists and
anesthesiologists could question whether the system would be able to perform
adequately.
1.7 Theory base and general literature review
Anesthesia is the controlled loss of awareness and sensation in a patient. This
allows for surgeons to operate on a patient without the patient being awake
or experiencing or reacting to the pain of the surgery. The first recorded
successful use of anesthesia was administered by William T.G. Morton who
sedated a patient, Edward Gillbert Abbott, by administering ether. This was
conducted on 16 October 1864 in "The Ether Dome" at Massachusetts General
Hospital [17].
When a patient is anesthetized, there are a number of responses and signals
from the patient that the anesthetist could use to measure the patient’s depth
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of anesthesia at a given time. These responses and signals include a varied
heart rate, a varied breathing rate, varying oxygen saturation in the blood,
changing temperature of the blood, and changing frequency of brain activity
[18]. These are influenced differently depending on the anesthetic drug used
and many of these responses have no linear correlation between their rate of
change and the depth of anesthesia. What has been noticed is that brain
activity does have a linear correlation to the depth of anesthesia, and so it
would be worth investigating these correlations [19].
Administering anesthetics to patients requires a thorough knowledge of
pharmacokinetics, the movement of drugs in the body, and pharmacodynamics,
the influence of the drugs within the body. There are various pharmacokinetic
models used to represent the movement of various anesthetic drugs in different
patient categories. For total intravenous anesthesia, the 3-compartment model
is commonly used [20] and for volatile anesthetics, like servoflurane, the 5-
compartment model is used [21]. Also, for intravenous anesthesia, the Schnider
and Marsh models are used for healthy adults [22], and the Paedfusor [23] and
Kataria models for children [24].
The interest in closed-loop control of general anesthesia has grown since
the bispectral index (BIS) monitor was introduced to determine the depth of
anesthesia [25]. Closed-loop control of anesthesia involves a controller that
adjusts its output based on the difference between the current input and a
reference setting. The inputs to the controller are measurements from the
process that is being controlled. There are various closed-loop control designs
available for use, each with their own advantages and disadvantages. Model
predictive control (MPC) is a type of controller that makes use of a model of
the system to make predictions of the system’s dynamics based on the actual
measurements.
1.8 Overview
This section introduces the shape of the dissertation. The chapters within will
be the following:
• Chapter 2 presents a literature review of concepts of anesthesia to give
the necessary background on which the ideas and methods of this dis-
sertation are based.
• Chapter 3 presents a literature review of concepts in control systems to
provide the necessary background for control system design considera-
tions.
• Chapter 4 describes the methodology used to conduct the work in this
dissertation.
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• Chapter 5 compares the control system constructed from a Proportional-
Integral-Derivative (PID) controller, to that constructed from a Model
Predictive Control (MPC) controller.
• Chapter 6 describes the effect of measurement noise on the system and
how the system would operate under those conditions.
• Chapter 7 discusses the results obtained as well as the how the system
would be incorporated in the field.
• Chapter 8 concludes the dissertation by summarizing the results and






This chapter investigates the literature available in the field of anesthesiology
as well as literature available in monitoring the depth of anesthesia a patient
experiences.
2.2 Anesthesia
Anesthesia is the controlled loss of sensation and/or consciousness in a medi-
cally controlled setting. Anesthesia can involve analgesia, the loss of pain sen-
sation; paralysis, the loss of muscle functionality; amnesia, the loss of memory;
and/or unconsciousness [2].
2.2.1 Types of anesthesia
There are 3 types of anesthesia available in medicine. They are local anes-
thesia, regional anesthesia and general anesthesia. The type of anesthesia
administered to a patient could depend on the type of surgery to be under-
taken, the age of the patient, the underlying medical condition that the patient
has, or the patient’s personal preference [26].
2.2.1.1 Local anesthesia
Local anesthesia is the loss of sensation in a relatively small area of the body
without causing a loss of consciousness. The effects of local anesthesia are
caused by suppressing the stimulation of nerve endings which are responsible
for transmitting pain signals to the brain.
7
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There are a number of methods used to induce local anesthesia, which
include applying a low temperature to the area, depriving the area of oxygen,
mechanical trauma and the use of local anesthetics [27].
It is important that the method used to induce local anesthesia is reversible,
impermanent and it should not irritate the area where it is applied. The
method used should also have low toxicity, the onset of the anesthesia should
be as quick as possible and the effects should last long enough for the proce-
dure to be completed without it wearing off. Furthermore, the chemicals used
should not need to be used at dangerous concentrations to have lasting effects,
they should not produce allergic reactions, they should easily undergo bio-
transformation in the body and they should not deteriorate when sterilized by
heat. Every local anesthetic available cannot meet all the criteria mentioned,
but they do satisfy the majority of the requirements [27].
Local anesthesia is commonly used for smaller procedures, like the removal
of wisdom teeth or a filling in dentistry, removing a mole and other minor skin
operations, biopsies and certain eye operations like cataract removal [28].
2.2.1.2 Regional anesthesia
Regional anesthesia involves administering anesthetic to a part of the body
larger than that involved in local anesthesia. Regional anesthesia blocks a
cluster of nerves in a certain part of the body to prevent pain and discomfort
during surgery. Similar to local anesthesia, regional anesthesia does not cause
unconsciousness, but it only blocks the nerves of an affected area to prevent
pain signals from reaching the brain [29].
There are mainly two types of regional anesthesia. The first includes pe-
ripheral nerve blocks, where anesthetic is injected near the desired nerve or
bundle of nerves to prevent pain sensations from being experienced at that
specific region, like the hands, feet or face. The second type is epidural and
spinal anesthesia, where the anesthetic is injected near the spinal cord and
this affects major nerves that block pain sensations from entire regions of the
body, like the lower abdomen, legs or hips [30].
The administration of regional anesthesia requires great skill and experi-
ence because the anesthetic needs to be injected at precise locations location
as this affects which regions are affected, and it reduces the risk of compli-
cations associated with incorrect administration, like nerve damage and in-
fection. For epidural and spinal anesthesia, it is even more important to be
precise because mistakes could affect heart rate, breathing, blood pressure and
other vital functions [30]. Patients receiving regional anesthesia also need to
be closely monitored because the location of administration may affect the
central nervous system, respiratory system or the cardiovascular system [30].
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Compared to general anesthesia, regional anesthesia is considered to be
more time-consuming and less reliable. The duration of its effects vary and the
depth of the anesthesia experienced by the specific region cannot be regulated
[31].
2.2.1.3 General anesthesia
General anesthesia involves an overall loss of consciousness for the patient.
General anesthesia involves experiencing a reversible state of unconsciousness,
coupled with a lack of awareness, pain suppression and memory loss [32]. Al-
though these are all the elements involved in the successful administration of
general anesthesia, each of these effects is achieved by administering different
drugs to the patient.
Using general anesthesia has a number of advantages over the other types
of anesthesia. General anesthesia in children is associated with fewer cases
of nausea and vomiting after the surgery, reduced procedural costs and less
operating room pollution and fewer cases of emergence delirium. Another
advantage is that general anesthesia has shown fewer interferences with evoked
potential monitoring [33].
2.3 General anesthesia
Anesthesiologists have the choice of two types of anesthetics to administer to
a patient to induce sedation. The anesthesiologist could opt for either of the
two options for the duration of the surgery or to use both at different points
in the surgery.
2.3.1 Inhalation anesthesia
Inhalation anesthesia was introduced in the 1940s accompanied by the de-
velopment of fluorine technology [34]. Inhalation anesthetics, also known as
volatile anesthetics, are delivered to a patient through the respiratory system
via a breathing mask.
The uptake and distribution of volatile anesthetics is depicted in Figure 2.1.
Initially, the volatile anesthetic is released from an anethesia delivery machine
with a vaporizer into a fresh gas mixture which is then delivered to a breathing
circuit. From the breathing circuit, the gas mixture is taken in by the patient
and it enters the patient’s lungs and alveoli. Through transcapillary diffusion,
the anesthetic then travels from the alveoli to the pulmonary veins which
transfer oxygen and the anesthetic to the blood. The blood is then distributed
to various tissues, like fat, muscle and vessel-rich groups, (the brain, liver and
kidneys). When the blood flows out of these tissues, it travels as deoxygenated
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blood to the pulmonary artery and it returns to the lungs’ alveoli. Here, the
blood is reoxygenated and receives more anesthetic to flow through the patient
again, and some of the anesthetic is returned to the alveoli and exhaled [35].
Figure 2.1: Flow diagram representing the administration and transportation
of inhaled anesthetic [35]
The inhaled anesthetic that is mixed with the fresh gas mixture is delivered
as a partial pressure, which is a portion of the total gas pressure delivered to
the patient. If the anesthetic is delivered at 1.5% in air at 760 mmHg or 1 atm,
then the ratios stand as follows: 157.2 mmHg of O2, 591.4 mmHg of N2 and
11.4 mmHg of the anesthetic [35]. Some common anesthetics used in volatile
anesthesia include isoflurane, desflurane and sevoflurane.
One advantage of volatile anesthetics is that their concentration in the
patient can be easily determined. By measuring the amount of drug expired
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by the patient through a mass spectrometer, the concentration of the drug
within the patient can be determined by comparing it to the amount of drug
administered to the patient [34].
2.3.2 Intravenous anesthesia
Intravenous anesthesia involves injecting the desired anesthetic directly into
the patient’s bloodstream. This has the advantage of the anesthetic being
administered with more precision by the infusion pump, as well as having
greater depth of anesthesia experienced by the patient during the surgery [34].
Intravenous anesthesia was established by Christopher Wren in 1656. He
used "a goose quill and a bladder to inject wine and ale into a dog’s vein" [36].
In 1843 and 1853, the hollow needle and hypodermic syringe were invented
and this allowed for the intravenous injection of drugs. By the 1900s, a wide
variety of drugs had been developed for intravenous anesthesia. One of these
includes the drug ether [36].
Intravenous anesthesia is also commonly governed by target controlled in-
fusion (TCI) where the anesthesiologist administers the anesthetic to reach
a targeted effect and/or plasma concentration. The infusion starts with the
injection of the anesthetic into the patient’s blood through a vein in the pa-
tient’s arm. The initial administration is a large bolus dose which is then
followed by a step-down infusion scheme. This step-down infusion scheme ad-
ministers anesthetic at decreasing rates of infusion until the patient is at the
desired plasma concentration or shows signs of adequate sedation [37]. Once
adequately sedated, the surgeon can begin with the surgery.
2.3.3 Drugs used in general anesthesia
Intravenous anesthetics at normal concentrations only function as hypnotic
drugs and do not contribute to any pain suppression. Anesthetics in this cat-
egory can be categorized as Barbiturates, Benzodiazepines such as midazolam
and diazepam, Phencyclidine like ketamine, Carboxylated imidazole like eto-
midate, and Isopropylphenol like propofol [37]. Since the early 1990s, propofol
has become a popular anesthetic in total intravenous anesthesia because of its
quick redistribution and metabolism, which then relates to quicker emergence
times for the patient [37].
Alongside the anesthetic, there are other drugs used during general anes-
thesia. These drugs are used to numb the patient’s pain responses as well as to
suppress muscle movements. Opioids, such as morphine, fentanyl, sufentanil,
alfentanil, or remifentanil, are commonly used in practice to suppress the sen-
sation of pain during the surgery. Opioids primarily target specific receptors of
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the central nervous system and limit neurotransmitter signals that would regis-
ter pain, from reaching the brain. One major side effect of using opioids during
surgery, especially in large doses, is that they affect the patient’s breathing.
For this reason, a patient needs to be assisted with breathing through artificial
ventilation [34].
Neuromuscular blocking drugs are the drugs used as muscle relaxants to
prevent the patient from moving during the surgery. Using these drugs make it
easier for the insertion of the artificial ventilation tubing as well as preventing
involuntary muscle movements and twitching during the surgery. Neuromus-
cular blocking drugs have no effect on the patient other than blocking muscle
movements, so they do not interfere with the anesthetics or opioids. When
short-duration muscle relaxation is required, succinylcholine can be used and
for longer effects, derivatives of curare such as mivacurium, rocuronium or
pancuronium, can be used [34].
2.3.4 Phases of general anesthesia
To achieve a stable plasma concentration of anesthetic in the patient for the
duration of the surgery, delivering the drug in varied amounts and infusion
rates is required. The steps taken to achieve this desired concentration are
divided into the three main phases of general anesthesia. These include: in-
duction, maintenance, and emergence [3].
In the case of intravenous anesthesia, the induction phase involves inserting
venous and arterial catheters, setting up EEG monitoring devices, starting the
administration of anesthetics and intubation. A bolus infusion is administered,
which is followed by a decreasing rate of infusion until the patient reaches the
desired plasma concentration and the desired effect is achieved [37]. This phase
needs much of the anesthesiologist’s attention because it can cause heavy stress
responses from the patient by increasing the patient’s heart rate and blood
pressure which could lead to fatal strokes and heart attacks in vulnerable
patients [3].
Then the operation begins and the anesthesiologist is responsible for the
maintenance of anesthesia. In this phase, the anesthesiologist monitors the
patient’s depth of anesthesia to prevent underdosing that could cause intra-
operative awareness, or overdosing during the surgery. This phase, though
critical, does not require as much attention from the anesthesiologist as com-
pared to the induction phase.
Lastly, at the end of the surgery, the emergence phase is conducted. This
is the phase when the anesthetic infusion is stopped and the patient slowly
gains consciousness. The monitoring devices and tracheal tube are removed at
the end of this phase [3].
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2.4 Depth of anesthesia
One of the most important steps in delivering appropriate amounts of anes-
thesia to a patient is being able to determine the current depth of anesthesia
experienced by the patient. Without monitoring the current level of anesthe-
sia experienced, the anesthesiologist runs the risk of either underdosing the
patient with not enough anesthetic, which could lead to awareness during the
surgery. On the other end, overdosing the patient with the anesthetic could
lead to the patient taking longer to gain consciousness at the end of the surgery
as well as potentially experiencing postoperative complications [32].
2.4.1 Electroencephalography (EEG)
The anesthetic delivered to the patient during anesthesia serves the purpose
of making sure that the patient remains unconscious throughout the duration
of the surgery. It, therefore, makes sense to monitor how conscious a patient
is right at the source of consciousness: the brain.
Electroencephalography (EEG) is the measuring and recording of the elec-
trical activity generated within the brain. The electrical signals are generated
from neurons which generate bio-electromagnetic fields through the electri-
cal impulses when they communicate. These impulses are then propagated
through the brain tissue, brain and scalp [8].
The EEG signal shows no repetitive patterns nor does it show any correla-
tion to specific underlying events. However, there are some measurable charac-
teristics of the EEG signal that show a monitoring of some brain functionality
[38]. The randomness of the EEG stems from neurons acting independently
because higher cortical function is associated with desynchronization. This
desynchronization and neuron independence is the root of conscious human
behaviour. Mechanisms that decrease levels of consciousness, like anesthesia
or sleep, have been shown to increase cortical synchrony [38], [39]. To an
extent, this decreases the randomness of the EEG signals.
When the EEG signals are generated, the overall postsynaptic current is
transmitted through the highly conductive cerebrospinal fluid and scalp, and
the less conductive skull. As the signals move through the highly conductive
layers, there is a significant amount of spatial smearing of regional voltage
differences [38]. From the transmissions, the EEG signals can be detected on
the surface of the skin using skin surface electrodes.
2.4.1.1 EEG monitoring on the scalp
To standardise the monitoring of EEG signals on the scalp for comparability in
research, the International 10-20 System layout was selected [40]. The name is
based on the 10% and 20% relative placement of the electrodes after identifying
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anatomical landmarks, and the system ensures that the symmetric spacing of
electrodes over the correct anatomical location on the patient’s head.
The first referential line is created by connecting the midline of the scalp
from the depressed concave region between the eyebrows, called the nasion,
to the inion, which is the convex point at the back of the skull. The second
referential line is created by forming a line from one ear’s tragus (the small
cartilage found on the anterior of the pinna of the ear) to the opposite ear’s
tragus, cutting through the first referential line. The two referential geometries
are then divided into segments:
S = {10%, 20%, 20%, 20%, 20%, 10%}
with S as the section spacing percentages of the relative total distance
between adjacent reference points. The placement of the electrodes is depicted
in Figure 2.2.
Figure 2.2: International 10-20 electrode placement system as seen from the
left (A) and from above (B). From the figures: A: ear lobe. C: central. F :
frontal. Fp: frontal polar. O: occipital. P : parietal. Pg: nasopharyngeal. T :
temporal. Z: zero (midline saggital) [41]
The placement of electrodes for the International 10-20 System layout is
an arduous process, but the placement of the 21 electrodes, with the two
reference earlobe electrodes included, ensures reliable reading of EEG signals
generated in the brain across the surface of the scalp. Using fewer electrodes
is possible, but this would introduce the risk of losing information during
the propagation of EEG signals from their sources in specific areas in the
brain. Additionally, patient cooperation is necessary as the patient’s hair then
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becomes an obstruction in the placement of the electrodes, so the patient’s
hair needs to be trimmed or removed to allow the electrodes to make sufficient
contact with the scalp for accurate readings.
2.4.1.2 EEG monitoring in the ear
As mentioned in [38], EEG signals’s postsynaptic current is transmitted through
cerebrospinal fluid, skull and scalp. As the EEG signal can be detected
throughout the mediums of propagation, [42] has investigated the possibility
of recording EEG signals from within the ear canal.
Figure 2.3 shows a cross section of the human ear consisting of 3 parts: the
outer ear (pinna and external auditory canal); the middle ear, the parts that
couple sound to the inner ear; and the inner ear (cochlea) that converts sound
to nerve signals, and has a bony casing. The auditory canal, from the pinna
to the eardrum, is roughly 26 mm long with a diameter of about 7 mm in the
average human ear.
Figure 2.3: Cross section of the average human ear [43]
Evoked potentials are electrical signals which propagate from within the
brain throughout the interior of skull in the conductive cerebrospinal fluid and
scalp [38] after the onset of a stimulus [44]. These signals can be picked up
from the inner ear and on the surface of the skin of the auditory canal [38]
and can therefore be picked up by the electrodes of an intra-ear EEG monitor
embedded on an earpiece designed to fit within the patient’s ear.
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Although intra-ear monitors have shown to record 10-20 dB lower ampli-
tudes than the scalp monitor’s recordings, both systems maintain a similar
signal-to-noise-ratio (SNR) [45]. Additionally, this development is a simpler
alternative to scalp EEG monitoring because it does not require lengthy setup
procedures and it alleviates the risk of artefact generation caused by skin
stretching and electrode movement that are common in scalp EEG monitor-
ing.
2.4.2 Monitoring the depth of anesthesia
The administration of anesthetics has a number of effects on the patient. With
these effects, there are a number of variables that can be measured from the
patient to determine the influence of the anesthetic that has already been ad-
ministered. During anesthesia, variables include the patient’s blood pressure,
muscle activity, and breathing. Unfortunately, these parameters have no direct
correlation to the current state of hypnosis experienced by the patient, as they
rather indicate whether the patient has received adequate muscle relaxant or
other drugs that affect these variables [46].
One other parameter that has been identified to correlate with the level
of hypnosis experienced is a patient’s brain activity. Therefore, it has been
identified that a patient’s electroencephalogram (EEG) can be analysed to
determine the depth of hypnosis experienced [38]. To derive insightful, infor-
mation from the EEG, a number of parameters have been derived from the
EEG to determine the level of hypnosis experienced by the patient.
2.4.2.1 EEG modelling
Sharma and Roy [46] sought to predict movement due to surgical stimulation
[47] sought to predict movement due to surgical stimulation. By measuring
blood pressure, heart rate and anesthetic concentration of volatile anesthetics
in terms of minimum alveolar concentration (MAC). Along with the autore-
gressive (AR) parameters, all these parameters were used as inputs to an
autoregressive model and neural network analysis to predict movement.
This study great improvement when EEG data was combined with other
parameters. However, the functionality of such a system comes at the expense
of large networks and computational power [38].
2.4.2.2 Power Spectrum Analysis
The power spectrum analysis is used in determining the distribution of the
EEG in its frequency domain. EEG signals can be classified into 5 frequency
bands at a range of frequencies. These include:
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• δ band ranging from 0.25 Hz to 3.5 Hz
• θ band ranging from 3.5 Hz to 7.5 Hz
• α band ranging from 7.5 Hz to 12 Hz
• β band ranging from 12 Hz to 32 Hz
• γ band ranging from 32 Hz to 70 Hz
Anesthetics administered to a patient affect the frequency distribution of
the EEG signals generated [48]. In an awake state, the EEG signal is predom-
inantly in the δ and the α bands. As the patient falls deeper into anesthesia,
the activity monitored in the α band decreases and the activity in the δ band
starts increasing.
To make findings from the power spectrum analysis useful for monitoring
the depth of anesthesia, the measurements need to be normalized to indices
using Fourier analysis as well as the spectral distribution. Two of such in-
dices are the Median Edge Frequency (MEF) [49] [50] and the Spectral Edge
Frequency (SEF) [51].
2.4.2.3 Bispectral Index (BIS)
The Bispectral Index (BIS) is an index that tracks the changes in EEG signal
and its properties during anesthesia. It has been found to be a more reliable
monitor of anesthesia when compared to the power spectral analysis since anes-
thesia slows or suppresses the EEG signals generated and the power spectral
analysis only tracks changes in the magnitude of the EEG signal [38].
BIS is a combination of a number of variables derived from the EEG signal
acquired via skin contact electrodes on a patient’s forehead [52]. The score
determined ranges from 100 and declines the deeper into anesthesia a patient
falls, with its minimum at 0 [53]. The scores are labelled as follows:
• 100 - 90: Awake
• 89 - 70: Light and moderate sedation
• 69 - 60: Deep sedation
• 59 - 40: General anesthesia
• 39 - 1: Deep hypnotic state
• 0: Flatline
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2.4.2.4 Wavelet Analysis
As functional as BIS is, one problem is that it is derived from the preceding 15
to 30 seconds worth of EEG data. This introduces problems if the score and
the patient’s current depth of anesthesia need to be used in real-time, or the
score needs to be implemented into a third-party system because of the use of
the prior 15-30 seconds of data which could be irrelevant to the current depth
of anesthesia [6].
It has been shown that the WAV Index [54], derived from wavelet analysis,
and the BIS are closely correlated. However, the WAV index analyses quick
changes in a patient’s EEG signals during induction, emergence and intra-
operative awareness and movement better than BIS does [55]. BIS has been
found to exhibit abrupt changes during anesthesia, but the WAV index has
shown a more gradual increase and decrease during anesthesia because it is
based on a per-second analysis of the EEG signals from the patient [55].
2.4.2.5 Evoked Potentials
Another method identified to detect variations in EEG is by monitoring evoked
potentials. Evoked potentials are electrical signals generated by the brain and
other parts of the central nervous system as a response to the agitation of an
external signal. Evoked potentials can be analysed based on the amplitudes
and latencies of the various peaks and troughs found in the signal. The changes
found in evoked potentials measured in succession can signify that the patient
is undergoing a change in response to the stimulus experienced [7], and thus
the patient’s state of anesthesia is changing.
2.5 Evoked Potentials
Evoked potentials (EP) are the responses generated by the nervous system
when an external stimulus is introduced. They provide quantitative numerical
data of neurological signals generated. They can be measured in terms of the
amplitudes, in volts, and latencies, in seconds [44].
The use of evoked potentials in clinical settings is favoured based on the
detail EP can reveal. They have the ability to detail abnormal sensory system
conduction in ambiguous neurological examinations, they can reveal the in-
conspicuous involvement of a sensory system when a nerve’s protective sheath
is damaged by disease, known as demyelination, and they can assist in mon-
itoring changes in a patients’ neurological state and the changes the patient
might be experiencing. Furthermore, the sensitivity and objectivity of their
examinations, as well as their ability to be recorded in patients that are co-
matose or anesthetized, are further advantages to using evoked potentials over
other detailed examinations [44].
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The disadvantage of evoked potentials is that they are susceptible to dis-
eases affecting the points of stimulation (for example, visual evoked potentials
are affected by the ocular disease in a patient), yet they are predominantly dis-
ease unspecified, so the disease affecting the EP cannot be specified. Addition-
ally, they show significant change as patients get older. To acquire artefact-free
recordings, they require some patient cooperation [44].
In theory, any external sensory stimulus can be tested and measured, but
in medicine, only a few have been found to be reliable in their measurements.
The problem with many of the evoked potentials that could be measured is
that they are longer latency responses related to higher cognitive functions [44].
The most commonly used stimuli include auditory stimuli, visual stimuli and
somatosensory stimuli and they generate the visual evoked potentials (VEP),
somatosensory evoked potentials (SEP) and auditory evoked potentials (AEP),
respectively [56].
2.5.1 Visual Evoked Potentials
Visual evoked potentials (VEP) are the evoked potentials generated from visual
stimuli. They are used to detail the conduction within the visual pathway from
the retina to the optic nerve, through the optic chiasma and optic radiations,
to the primary visual cortex [44], [57], depicted in Figure 2.4.
VEPs are recorded by placing three electrodes across the occipital region
of the scalp, with a fourth electrode placed on the mid frontal region as a
voltage reference. Two more electrodes are placed on the lower eyelid of each
eye to record the average activity taking place in that region [44]. These are
depicted in Figure 2.5. The visual stimulus is a high contrast black-and-white
"checkerboard" image occupying 20° - 30° of the field of vision. The black
and white squares periodically change positions and the averaged responses
recorded during these transitions is the VEP [44].
The average responses of the VEP of binocular and monocular "full-field"
simulations are depicted in Figure 2.5 [44]. The components of the VEP signal
are named according to their polarity (P for positive when the wave deflec-
tion is downward or N for negative when the wave deflection is upward) and
the approximate time to which they occur after the "checkerboard" pattern
reversal. Therefore, the electrode placed at the midline occipital region reads
a negative N75 component, followed by a significant P100 component. The
P100 latency of the midline electrode is taken as the time from the stimulus
generation to its registration. The vertical lines represent a normal patient’s
mean and 99.5% confidence intervals of the P100 latency [44].
The latency of the P100 trough in normal patients can be affected by the
brightness and contrast of the checkerboard displayed and even the viewing
angle of the checkerboard [58]. Additionally, other factors like the pupillary
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Figure 2.4: Diagram representing the visual pathway from the retina to the
visual cortex [57]
size, gender and age of the patient affect the VEP [59]. Therefore, for older
patients with deteriorated visual acuity, it may be necessary to use larger
checks to acquire usable VEP data. It has also been shown that sedated
patients and those in anesthesia show deteriorated VEPs [60].
If the P100 latency falls out of the confidence interval range of 99.5%, it can
be assessed as a visual abnormality in the patient. These abnormalities can
range from binocular delay, monocular delay, monocular absence or monoc-
ular waveform abnormality, as depicted in Figure 2.6 [44]. Causes of these
abnormalities could range from optic nerve damage or inflammation, glau-
coma, diabetes, tumours compressing the optic nerve and many others [56].
2.5.2 Somatosensory Evoked Potentials
Somatosensory evoked potentials (SEP) are evoked potentials measured at
various points on the skin as a response to nerve stimulation on the surface
of the skin. The electrical activity measured over the scalp from this nerve
stimulation depicts cerebral action potentials and these potentials are best
observed contralateral to where the nerve was stimulated [61].
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Figure 2.5: Visual evoked potentials (VEPs) and pattern electroretinograms
(ERGs) generated by full field stimulation. The vertical cursors show the mean
latency and its 99.5% confidence limits [44]
Figure 2.6: Examples of abnormalities in the VEP [44]
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The SEPs are recorded relative to a stimulus with a pretrigger. To gener-
ate the stimulus, the recommended electrical stimulus should be a continuous
square wave pulse of a 0.1 - 0.2 ms duration. Additionally, when stimulating a
motor- and sensory-fibre containing nerve, the intensity of the stimulus should
exceed the motor threshold necessary for evoking a muscle twitch, but not too
high as to cause pain [61].
To record the SEP most effectively and efficiently from the scalp, skin
surface electrodes should be placed according to the International 10-20 System
[62], depicted in Figure 2.2. Only seven electrodes are necessary: Fz, Cz, Pz,
F3, C3, P3 and a reference earlobe electrode. The electrocortical locations that
should be used contralaterally to the side which the stimulation occurs are the
F3 and the P3. The impedance of the skin on which the electrodes are placed
needs to be less than 5 kΩ [61].
Similar to the VEPs, the waveform peaks are labelled according to their
polarity and their latency. The size of the amplitudes represent the magnitude
of the incoming conducted stimulus and the length of the latency shows the
anatomical location along the somatosensory pathway where the stimulus was
administered [61]. SEPs can also be described as "short-latency" if the signal
occurs within the first 40 ms from a stimulus in the upper limbs, and within 50
ms for the lower limbs. Peaks and troughs longer than 45 ms have a higher risk
of variability as they are more susceptible to cognitive factors [63]. For this
reason, the short-latency SEPs are more useful to study because they have less
variability among normal patients with typically functional nervous systems
[61].
Figure 2.7 depicts an example of SEP extracted from normal patients [44].
Figure 2.7a depicts the median nerve stimulation SEP test setup of two pa-
tients. The stimulus was introduced on the wrist and the SEPs were recorded
along the median nerve en route to the somatosensory cortex. The bottom
waveform shows the bipolar response of the stimulus between two of the de-
picted chest electrodes and the top waveform depicts the N20 and P23 peaks
in their expected locations.
Figure 2.7b the SEPs recorded from an impulse introduced to the tibial
nerve, en route to the brain. On the left, a normal tibial stimulated SEP is
depicted, and an abnormal SEP on the right. The normal patient’s SEP shows
normal P37 and N45 peaks, while the abnormal SEP responses show attenu-
ated responses and delayed latencies even before the onset of the stimulation.
SEPs are commonly used to investigate patients who could have multiple
sclerosis and myoclonus. They are also used as a guide to decision making
in post-traumatic and anoxic ischaemic coma in the ICU, as well as intra-
operatively monitoring the efficiency of the sensory pathways during spinal
curvature corrections [44].
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(a) Depiction of short-latency somatosensory evoked potentials (SEPs) occurring
normally after stimulation of the median nerve (left) and normal median nerve
short-latency SEPs relative to signals on the right of Fig 2.7b (right)
(b) Posterior tibial nerve SEP measured en route to the brain (left) and a dispersed
P37 trough with lingering latency relative signals on the right of Fig 2.7a (right)
Figure 2.7: Examples of measured SEP signals [44]
2.5.3 Auditory Evoked Potentials
Auditory evoked potentials (AEPs) are the evoked potentials generated in the
brain when an auditory stimulus is introduced. They are generated by fluc-
tuations in the electrical potential across neuronal membranes in the auditory
system [64].
Similar to the SEPs, AEPs can only be detected and recorded relative
to a stimulus, and in this case an auditory stimulus. AEP signals are much
smaller than the EEG signals in which they are found, therefore the only way
to extract them from the EEG signal is by introducing multiple occurrences
of identical stimuli and averaging the response monitored in the EEG signal.
The EEG signals will vary widely in a certain time-frame and the AEP will
be detected as the constant signal in the same time-frame [64].
To generate usable AEPs, the stimuli introduced is the sound of consistent
clicks or tonebursts. The auditory stimulus needs to be delivered at a comfort-
able, audible level for the patient, and not too loud for patient when awake.
To monitor the AEPs on the scalp, the electrodes are placed according to the
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International 10-20 system, as depicted in Figure 2.2, and should be placed by
Cz, or on other points on the same midline as Cz (e.g. Fz or Pz), with the
same earlobe electrode reference [64].
There are two classifications used in AEPs. The first is the transient AEPs
which are generated by the auditory stimulus and wear off before the next
stimulus is introduced. The second classification is the steady-state AEPs,
which are generated when successive stimuli are delivered before the AEP
decays. They then depict sinusoidals with the same frequency as the stimulus
introduced. The transient responses can be further classified into the:
• Fast response which occurs around 6 - 10 ms;
• Middle response which occurs around 10 - 50 ms;
• Slow response which occurs around 50 - 250 ms;
• Late response which occurs at times after 250 ms.
A normal AEP signal is depicted in Figure 2.8. The brainstem auditory
evoked potential (BAEP) is the fast response. It is commonly resistant to
the effects of anesthetics, and is often used to test the reliability of the audi-
tory pathways during neurosurgical procedures. The middle-latency auditory
evoked potential (MLAEP) is the middle response commonly used to measure
the effects of an anesthetic on a patient. It has been shown that the shape of
the MLAEP in normal awake awake patients differs from that of patients in
anesthesia [65], [66]. The slow and late evoked potentials are considered to be
too sensitive to the effects of anesthesia, and therefore cannot be used [64].
Mantzaridis and Kenny [65] developed a new AEP index, AEPidx, used
to evaluate a patient’s depth of anesthesia. This AEPidx is a mathematical
derivative of the absolute difference between every two successive segments
of the AEP waveform. Unfortunately, the details for this index are propri-
etary knowledge. Fortunately, it has also been found that the latencies of the
MLAEP signals can be used to monitor the depth of anesthesia a patient expe-
riences because the latencies of the different peaks and troughs of the signal are
delayed the deeper a patient drifts into anesthesia [65], [66]. The Nb trough’s
latency has been shown to have the strongest correlation to the AEPidx to
monitor the depth of anesthesia [65].
2.6 Pharmacokinetics and
Pharmacodynamics
The patient needs to be closely and carefully monitored during the procedure to
prevent any adverse effects that the anesthetics could have on the patient. To
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Figure 2.8: An example of a healthy, awake patient’s AEP [67]
administer appropriate amount of anesthetic to the patient, we need a thorough
understanding of pharmacokinetcs (PK) and pharmacodynamics (PD).
Pharmacokinetics describe the movement of administered drugs within the
patient’s body. This includes absorption, distribution, metabolism and elimi-
nation of the drug. The movement of a drug is highly dependent on patient-
specific parameters, which include age, sex, weight, and height, as well as the
chemical properties of each drug. Pharmacodynamics describe what the drug
does to the body once it has entered the body. This involves receptor binding,
post-receptor effects and chemical interactions [68].
2.6.1 PK-PD models
There is different pharmacokinetic and pharmacodynamic (PK-PD) theory re-
lated to the type of anesthetic drug being administered, and therefore, different
PK-PD models are needed for different types of anesthesia.
2.6.1.1 PK model for volatile anesthetics
For inhalation anesthesia, where a gas such as isoflurane is used to induce
and maintain anesthesia, the PK model consists of a five-component compart-
mental model depicted in Figure 2.9 [21]. In this model, the anesthetic is
first delivered to the lungs. The anesthetic is then distributed to the vari-
ous compartments and back via the rate constants kij, where i is the origin
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compartment and j is the destination. The rate constants with destination 0
represents the elimination rate constants. The compartments include the ves-
sel rich group (VRG), which includes the brain, heart, liver, kidneys and spinal
cord; the muscle group; the fourth compartment, which is the fat around the
vessel-rich organs; and the fat group.
Figure 2.9: 5-compartmental model of the PK of the patient for inhalation
anesthesia [21]
2.6.1.2 PK model for intravenous anesthetics
For intravenous anesthesia, where the drug is directly infused into the pa-
tient’s bloodstream, the three-compartmental mamillary model is commonly
considered. Although one- and two- compartmental PK models do exist, their
functionality is restricted to a very small number of anesthetic agents [20]. In
the three-compartmental PK model, the amount of drug leaving one compart-
ment is the input of the adjacent compartment [20], depicted in Figure 2.10.
The compartment V1 is the primary compartment, which represents the
first point of entry of the anesthetic, being the blood; compartment V2 is the
fast compartment which represents muscle; and V3 is the slow compartment,
which represents fat. The parameters q1, q2 and q3 represent the drug quantities
in each compartment over time and the kij parameters are rate constants
representing the mass flow from the i to the j compartment [68].
Various PK-PD models have been developed and are available for use.
These different models have been developed from testing the interaction of the
anesthetics to different patients with similar characteristics. From there, dif-
ferent assumptions were made per model and parameters were determined to
fit these models. Many of the models were designed based on young, healthy
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Figure 2.10: 3-compartmental mamillary model of the PK of the patient for
intravenous anesthesia
adults and a smaller percentage of models is based on the obese and on pae-
diatrics.
The models used for healthy, young adults undergoing general anesthesia
with the drug propofol include the Marsh [22], [69] and Schnider [22], [68]
models; and for children, the Paedfusor [23] and Kataria [24] models are used.
There is also an overarching Eleveld model [70] which is compatible with a
wide variety of patients, but it has not been included in the target-controlled
infusion anesthetic pumps because it is relatively new [37].
2.7 Conclusion of the anesthesiology
literature review
Using the in-depth research conducted regarding anesthesiology and the types
and methods available to sedate a patient, the methodology of administering
general anesthesia using the intra-ear monitor designed in [10] can be drawn





A control system is a system that governs the behaviour of a defined variable.
It controls the variable by either keeping it constant in the face of external
disturbances, or it changes the parameter according to a given trajectory [5].
Control systems are commonly used to control complex systems that would
be harder to control manually. As functional as control systems are, they need
to be meticulously designed and rigorously tested before implementing. In the
face of external disturbances, these systems could yield disastrous results. If
they encounter unforeseen disturbances, they run the risk of failing and the
failure of the controller alone could jeopardize the functionality of the whole
system [71].
Examples of control systems in everyday life would include the cruise con-
trol of a car and the automated flight control sequences of an aeroplane. The
human body can also be seen in terms of a number of control systems that
keep the body functioning normally. One of these physiological control sys-
tems is heart rate control, controlling how much blood, nutrients and oxygen is
supplied to the body and its various organs under various circumstances [71].
There are a number of types of control systems available. They all have
unique approaches to the control problem and have varied levels of complexi-
ties, but the end goal of each type of control system is to drive the behaviour
of the system under control.
3.1 Proportional-Integral-Derivative (PID)
Control
Proportional-Integral-Derivative (PID) controllers are one of the most used
controllers in industry. They have gained popularity because of the simplicity
28
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of their structure, ease of design and relatively low implementation costs [72].
PID controllers are made of three separate controllers that work together
to provide control of a system. The three controllers are used to adjust the
controller output to be: proportional to that of the error signal, which is
the difference between the reference signal and the signal measured from the
system; to remove the residual error aggregated from the previous values of the
error signal; and to reduce the effect that sharp, sudden signal disturbances
will have on the system [73].
PID is widely used in industry because of low implementation cost, but it
could be risky to implement for a highly complex system such as the human
body. In a medical setting, there is the risk of stability issues if there are dis-
turbances during the procedure as the controller could potentially administer
a correcting amount of drug regardless of the effect that this unprecedented
infusion would have on the drug concentration in the patient, which could,
potentially, be fatal [74].
3.1.1 Classic PID control structure
The classic PID control structure is depicted in Figure 3.1. The signal y and
ySP are the output and the set-point of the output, respectively. The signal e
is the error signal, which is the difference between the output and the set-point
and uPID is the control input to the plant from the PID controller.
The three controllers, the P-, I- and D-controllers, each contribute to the
performance of the PID controller. The proportional (P) feedback control of
the controller is linearly proportional to the error of the controller and the
control signal is instantaneously related to the system error [73]. Therefore,
the proportional control signal is:
uP (t) = kP e(t) (3.1)
The parameter kP is the proportional gain that amplifies the error signal.
The integral (I) feedback control signal is linearly proportional to the in-
tegral of the system error. This is used to decrease the steady-state error of





The parameter kI is the integral gain. The integral translates to a summation
of all the previous values of the error signal.
The derivative (D) feedback control signal is used to decrease the overshoot
of the signal and improve the closed-loop stability of the system. This is
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achieved by having the derivative gain term kD proportional to the rate of
change of the system error [73]. The control signal is thus:
uD(t) = kD ė(t) (3.3)
Therefore, the plant input uPID in Figure 3.1 is:
uPID = kP e(t) + kI
∫ t
t0
e(τ)dτ + kD ė(t) (3.4)
Figure 3.1: The basic PID control structure
Selecting PID parameters appropriately for the system has been researched
widely. There are a couple of tuning methods that stand out.
3.1.1.1 "Ziegler-Nichols" tuning method
Ziegler and Nichols developed their popular "Ziegler-Nichols" tuning method
and published their work in two papers [75], [76]. Basically, their tuning
method involves calculating controller parameters based on testing the plant
in an open-loop and then testing the plant in a closed-loop [73], [77].
3.1.1.2 Predictive PID
Predictive PID is another tuning method available for the PID controller. The
control structure includes the prediction of the output of the plant and the
controller then recalculates the control action to be undertaken by using the
data of the future set-point [78].
The algorithm for predictive PID involves reformulating the generalized
predictive controller with steady-state weighting into a model-based PID con-
trol structure [79].
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3.1.1.3 Integral Performance Criteria
Integral performance criteria are also used when designing PID controllers, for
selecting parameters that give the desired response [80], [81]. All performance
criteria are dependent on the error signal and in a general sense, the lower the
value of the performance criteria, the more stable the system is.
The Integral Squared Time Error (ISTE), in (3.5), highlights the larger
errors and emphasizes consistent errors [82]. Lastly, there is also the IST2E,
which is the Integral of the Squared Time-squared weighted Error and the













The paper [80] gives the tuning rules which highlight the integral perfor-
mance criteria values required for tuning the PID controller.
3.1.2 Fuzzy PID
The classic PID structure does have the drawback of being insufficient to
control more complex systems, such as those containing time delays, signifi-
cant oscillations, as well as systems containing non-linearities or multi-input
multi-output systems (MIMO) plants [83], [84]. To make provision for these
problems, investigations have been undertaken to combine fuzzy logic control
technology with the classic PID controller for better performance.
Fuzzy logic is closely linked to human thinking and natural language pro-
cessing of information. In control terms, fuzzy logic control is a control al-
gorithm that can set linguistic control strategies, like if-then rules, into an
automatic control strategy [85].
The fuzzy logic controller is essentially made of three components as de-
picted in Figure 3.2 [72]. The Fuzzification interface involves measuring the
input and converting the data into fuzzy set activation levels to provide in-
put to the Fuzzy Inference Mechanism. The Fuzzy Inference Mechanism is
made of the "data base" and "linguistic control rule base" which classify the
incoming data values according to the defined rule base. From here, the sys-
tem’s "decision making" logic decides on the fuzzy control action that will take
place. Lastly, the Defuzzification interface takes the fuzzy control action and
transcribes it into non-fuzzy control action [85].
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Figure 3.2: Components of a fuzzy logic controller [85]
3.2 Model Predictive Control (MPC)
Model predictive controllers are advanced control systems which solve on-line
optimization problems to minimize output error and control effort, subject to
the constraints and dynamics of system states and controls. A unique feature
is that they make use of a model of the system within the controller to optimize
the control actions taken.
The changes in the manipulated variable are carefully selected based on
the prediction of system outputs. The system predicts several future actions
to be taken on the manipulated variable over the "prediction horizon", but
only the first computed change is implemented. After the implementation,
the model output is computed and the model parameters are updated. Then,
the possible future actions are predicted again over the same length of the
prediction horizon.
3.2.1 Principles of Model Predictive Control
The operation principle of an MPC controller is depicted in Figure 3.3. The
MPC controller predicts the future behaviour and dynamics of the system over
a defined prediction horizon and, over the period which the MPC computes
control actions, called the control horizon, it determines the inputs to be deliv-
ered to the system to optimize the open-loop performance objective function
[86].
The first computed control action is executed during an interval of δ from
time t, and the controller has to recalculate the control actions, prediction and
optimization, from t+δ. This process is repeated for every δ sample time-units
[86].
Another advantage of using the MPC controller is the simplicity of includ-
ing constraints in the controller. Most systems handle constraints by imple-
menting overrides, logic-based saturation or through split range controllers.
Such constraint implementations are difficult to design, modify and maintain.
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Figure 3.3: The basic operating principle of the MPC
In an MPC controller, the system constraints can be included directly into the
controller and the controlling algorithm is able to find optimal solutions that
operate within those working constraints [87].
3.2.2 MPC model structure
The model structure of an MPC controller is depicted in Figure 3.4. The plant
model is a state-space or a transfer function description of the system. The
plant model has its manipulated variables, u(k), and the optional inclusion
of measured disturbances v(k), as inputs. The outputs include the measured
outputs y(k) and the optionally included unmeasured outputs yu(k). The
disturbance models, d(k) for the input disturbance model and yod(k) for the
output disturbance model, can be included optionally [88].
The measurement noise differs from the unmeasured input and output dis-
turbances, as measurement noise specifies the expected noise model for the
measured data, and can be implemented without the unmeasured output dis-
turbance or the unmeasured input disturbance.
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Figure 3.4: The model structure of MPC [88]
3.2.3 Linear MPC
Linear MPC is defined as an MPC controller incorporating a linear model of
the system under control. These linear models are commonly described as
state-space models, but they could also be represented as transfer functions,
also known as input-output models. Models in state-space form are represented
in the form:
x(k) = Ax(k − 1) +B u(k − 1) y(k) = C x(k)
where x is the vector of states, u is the vector of inputs, and y is the vector
of outputs. The parameter k is the discrete-time sample number. The matrices
A,B and C are the system matrices for the state-space model [87].
State-space descriptions are favourable because of the simple depiction of
multi-variable systems, easy analysis of closed-loop properties and simple im-
plementation of on-line computation [89] Additionally, the use of the state-
space representation of models has opened the door for linear systems theory,
which includes linear quadratic regulator theory [90], Kalman filtering theory
[91] and internal model principles [87].
Linear models are the favoured models to use for MPC controllers as they
can be solved quickly and the optimization problem can be represented as a
linear or quadratic problem.
3.2.4 Non-linear MPC
In many systems, non-linearities are introduced because of the desire to have
models that closely resemble the dynamics of the system in the real world.
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These non-linearities are commonly introduced by incorporating the funda-
mentals of a system, like the conservation of mass, momentum and energy in
physical systems, or the relationships of chemical kinetics in chemical processes
[89].
MPC controllers that use non-linear models are well suited for systems
which have process conditions that vary significantly over the course of opera-
tion. Despite the complexities of such systems, the use of non-linear MPC has
actually been promoted by the availability of increasing computing power [89].
For systems with highly non-linear models, some of the following techniques
are used to achieve sufficient control.
3.2.4.1 Adaptive MPC
The first method available is the use of adaptive MPC. As a non-linear system
controlled by an MPC runs, the prediction accuracy can degrade over time
and the MPC’s performance can quickly become obsolete. Adaptive MPC can
adapt the prediction model for various operating conditions. The adaptive
MPC controller does this by dividing the model into various linear models at
different operating points. These linear models then have linear constraints
and solve a linear cost function. Therefore, at the beginning of each control
interval, the adaptive MPC controller calculates the prediction using model
parameters appropriate for the current running conditions [92].
3.2.4.2 Gain-scheduled MPC
This method differs from the adaptive MPC because instead of having different
model parameters for various operating conditions, the gain-scheduled MPC
switches between various MPC controllers which operate in different operating
conditions of the non-linear model. The various MPC controllers will then have
linear constraints and solve a linear cost function. This method could be more
memory intensive as multiple MPC controllers need to be saved in the system’s
memory for switching, but the computational power of using this method can
be reduced by preventing the inactive controllers from computing predictions
during operation [93].
3.2.4.3 Non-linear MPC
If the non-linear plant model cannot be simplified by various operating points
with linear constraints and cost functions, then non-linear MPC would need
to be used. Computationally, this is the most demanding method as the op-
timization function becomes non-convex and finding the global optimum be-
comes complex. This method uses the most accurate representation of the
plant and the predictions made by the controller more accurate than the those
determined by the other methods [94].
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3.3 Control system performance evaluation
An important aspect of control system design also lies in the evaluation of the
performance of the control system during and after the design. This can help
the control engineer determine that the design meets the design specifications
set and that the designed system is ready to be implemented.
In the context of automated control of anesthesia, the control objectives
are described as: controlling the average value of the manipulated variable
to remain within a given limit, minimizing controller oscillation within the
given limits, and guaranteeing stability in the controller performance by either
reducing the oscillations a controller experiences or keeping the oscillations
within the defined performance limits [95], [96].
A suitable set of performance evaluation criteria is given below.
3.3.1 Time-domain specifications
An important part of control system design involves considering the time re-
sponse of the system. The performance specifications of a control system
involve certain requirements that the system needs to adhere to when a step
input is introduced to the system.
A typical step response of a control system is depicted in Figure 3.5. The
parameter tr is the rise time, which specifies the time between 10% and 90%
of the final value. The settling time ts defines the time taken for the system’s
step response oscillations to decay. It is often defined as the time taken for
the system’s oscillations to reach the range of 5%, 2% or 1% of the final value.
[73].
The parameters tp and Mp are the peak time and overshoot, respectively.
The peak time defines the time taken for a step response to reach its max-
imum value, and the overshoot defines the maximum amount that a system
response overshoots its final value, and this is often stated as a percentage
[73]. Depending on the application of the controller, the a certain amount of
overshoot could be allowed, which then defines the system as an underdamped
system. Otherwise, if no overshoot is allowed for the application, the system
is then defined as an overdamped system and the system’s step response will
rise smoothly to the final value with no oscillations.
3.3.2 Integral Performance Criteria
Integral performance criteria [98], [99] can also be used to evaluate the per-
formance of a control system. All performance criteria are dependent on the
error signal, which is the difference between the reference signal and the system
output.
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Figure 3.5: A typical step response of a control system [97]
The integral performance criteria used include the Integral Absolute Error
(IAE), with its equation in (3.8). It determines the integral of the error signal
over the entire simulation and all errors hold the same weight. There are other
performance criteria. These include the Integral Squared Error (ISE), in (3.9),
squares the error signal and then determines the integral. This highlights
larger errors more than the rest of the errors in the system. The Integral
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3.3.3 Performance error-based evaluation parameters
According to [96], [100], [101], the performance of a closed-loop control system
used for muscle relaxants can be evaluated using performance error(PE)-based
evaluation parameters. These include the median performance error (MDPE),
median absolute performance error (MDAPE), and wobble.
The performance error (PE) of a given period is calculated as:
PE =
Measured value − Reference value
Reference value · 100 (3.11)
The MDPE is a measure of the bias of the controller performance. It
describes if the measured values are symmetrically above or below the refer-
ence value, with a positive MDPE or a negative MDPE, respectively. It is
determined as:
MDPEi = Median{PEij, j = 1, ..., Ni} (3.12)
where Ni is the number of PE values obtained for the subject i.
The MDAPE is a measure of the amplitude of possible bias and errors from
the reference value the controller experiences. It is determined as:
MDAPEi = Median{|PEij|, j = 1, ..., Ni} (3.13)
with Ni as the number of PE values obtained for the subject i.
Wobble represents the oscillations of the controller and it measures the
intrasubject variability in the measured values. It is determined as:
Wobblei = Median{|PEij −MDPEi|, j = 1, ..., Ni} (3.14)
3.4 Conclusion of the control systems
literature review
Using the research conducted regarding control system and various types avail-
able, the design of a closed-loop control system administering general anesthe-
sia can be undertaken in Chapter 4. The MPC controller will be used as it






This study will focus on designing a closed-loop controller interfacing intra-ear
monitoring with general anesthesia.
In order to achieve this aim as well as to answer the research questions,
the design and implementation of such a system needs to be thought through
and analysed. Considering the information listed in the literature review and
applying the relevant information, a practical design of a closed-loop control
system can be achieved.
4.2 System design
The system will be designed is to read the current depth of anesthesia experi-
enced by the patient, then deliver the desired amount of propofol intravenously
to a patient during general anesthesia. It is recommended that such a system
should be designed for application during the maintenance phase of anesthesia
[3]. Automating the induction phase could be feasible, but it is more intricate
and involved because the anesthesiologist is required to sedate the patient
and monitor that the patient does not show any signs of awareness through
movement, increased breathing rate or increased heart rate.
The signals monitoring the patient’s depth of anesthesia will be read into
a control system that will compare the current depth to the desired set-point.
If the depth of anesthesia experienced is lower than the specified set-point, the
system will administer anesthetic to deepen the anesthesia. If the depth of
anesthesia experienced is greater than the set-point, the system will pause the
infusion so the patient can metabolize some of the anesthetic that is already
in his/her system, lightening the depth of anesthesia experienced and this will
slowly return the patient back to the desired level of anesthesia.
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As this process will be continuous throughout the maintenance phase, it
will be implemented as a closed-loop control system. The system architecture
is depicted in Figure 4.1.
Figure 4.1: Block diagram of the system architecture
4.2.1 Reference
The reference signal is the set-point governing the desired depth of anesthesia
the system will be targeting. For the system, the reference can be selected
as either the desired latency of the Nb trough in the MLAEP, which will be
read from the intra-ear monitor [10], or the anesthetic plasma concentration,
required to keep the patient sedated.
4.2.2 MPC Controller
It will be advantageous to incorporate some information about the patient
into the system so the infusion algorithm of the controller is able to base
its calculations on the patient’s parameters. Therefore, a Model Predictive
Controller (MPC) is used with a model of the patient incorporated into the
controller.
Linear MPC will be used for the closed-loop control of anesthesia because
of the linearized patient model described by the PK-PD model. The controller
will determine how much anesthetic needs to be infused into the patient during
the maintenance phase based on measurements of the patient’s current depth
of anesthesia and the reference signal.
The output of the MPC is u and this will be the signal to drive the anes-
thetic infusion pump administering anesthetic to the patient. The measured
disturbance, md, is the amount of disturbance that the system would need to
account for.
4.2.3 Plant
The plant is depicted by the dashed lines in Figure 4.1. The plant includes the
anesthetic infusion pump, the patient, the intra-ear electrode reading the EEG
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signals from the patient and the intra-ear monitor extracting the MLAEP from
the EEG signals to determine the Nb latency.
4.2.4 Nb latency output
The intra-ear monitoring system will be monitoring the latency of the Nb
trough throughout the procedure, and that will be the measured output fed
back into the system to close the loop.
4.2.5 User interface
For a practical system implementation, a user interface will be necessary to
allow an anesthesiologist to control the operation of the closed-loop control
system. It will be used to input patient data for the PK-PD model used in the
MPC controller as well as to set the reference plasma concentration or latency.
It will also be used to monitor the measured latency and plasma concentration
from the patient to alert the anesthesiologist of the level of anesthesia currently
experienced by the patient.
4.3 Simulation
The system will be simulated using a Simulink model which is available in
MATLAB. MATLAB is a programming language predominantly used for nu-
meric and other algebraic computations. It comes with its own Integrated
Development Environment (IDE) and a vast number of libraries, apps and
built-in functions [102], [103]. One of these includes the simulation software
Simulink.
Simulink is a MATLAB add-on that allows for graphical simulation, mod-
eling and analysis of dynamic systems. It allows for the graphical user interface
(GUI)-based construction of block diagrams to design and model various sys-
tems using a wide variety of pre-defined and custom block libraries. Simulink
also aids in a system-level approach to design, automatic code generation,
testing and verification of designed systems [104].
In Figure 4.2, the Simulink model used to simulate the closed-loop control
system is depicted. The elements within the model are described below.
4.3.1 Reference
The Simulink model allows for two types of reference signals to be used: a
reference latency or a reference plasma concentration. Either of these two
references can be selected by connecting the switch to the desired reference.
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Figure 4.2: Block diagram of the system structure in Simulink
The reference plasma concentration, in µg.ml−1, drives the system to infuse
propofol to reach the specified plasma concentration in the patient.
The reference latency is derived from the desired plasma concentration, Cp,
required during the maintenance phase. According to [37], the recommended
Cp concentration for the maintenance phase is 3 µg.ml−1. From the dose-
response model (4.3), the corresponding latency is 63.0267 ms.
4.3.2 Patient model
The patient model consists of the blocks depicted in Figure 4.3. The model
consists of the state-space model of the Paedfusor PK model and the transfer
function of the patient’s PD model. The PK model is used to determine
the plasma concentration which is then used to determine the latency of the
patient’s Nb trough at that specific time. The PD model is used to determine
the concentration of the anesthetic in the patient’s brain, called the effect-site,
at a specific time.
The patient’s PK model is a state-space representation the patient. The
state-space model has infusion rate as the input u, the plasma concentration
as the output Cp and three states q1, q2, and q3, which represent the drug mass
in each compartment of the 3-compartmental model, as mentioned in Section




















+ 0 · u (4.2)
The output of the PK is the input of the PD model. Both their outputs are
similar, however they have a time delay difference. The effect of the effect-site
concentration, Ce on the 3-compartmental PK model is small and insignificant,
thus it can be assumed that the effect-site will have a similar end concentration
as Cp, but the concentration will only be reached later than that of Cp, at the





Figure 4.3: Diagram of the PK-PD in the Patient Model block
4.3.3 MPC
Simulink provides the MPC Designer software, to assist in the development of
MPC controllers, and to allow a number of controller parameters to be defined.
The internal model used in the MPC design is the state-space Paedfusor
PK model of the average patient in [66]: an 8.6 year old patient who weighs
29.2 kg. The patient’s state-space model used is similar to that shown in
(4.3.2) and (4.2).
The parameters of the MPC are listed in Table 4.1. The sample time
(Ts) selected for the MPC block was determined from [37], where the intra-
venous propofol maintenance infusion is administered every 10 seconds. As
recommended by [105], the prediction horizon is chosen as a value comput-
ing an adequate amount of future predictions, saving computing resources.
The control horizon is chosen as 10% of the prediction horizon. The manipu-
lated variable upper and lower limit were set based on the guidelines in [106],
where the lowest infusion rate possible is 0 mg.min−1 and the highest is 250
mg.kg−1.min−1.
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Adjusting the robustness of the controller block can be achieved by using
the Control-Loop Performance slider in the MPC Designer, shown in Appendix
C. The robustness of the system is adjusted to reduce the step response’s over-
shoot and to shorten the settling time. By adjusting the slider, the manipu-
lated variable rate weight and the output variable weight are adjusted.
Table 4.1: MPC parameters
Parameter Value




MV minimum constraint 0 mg.min−1







In the practical system, the output of the MPC is the signal which drives
the infusion pump administering anesthetic to the patient. For the simulated
system, the infusion pump is considered as a simple pass-through block be-
tween the MPC and the patient model.
4.3.4 MLAEP latency and plasma concentration
correlations
To date, there has been limited research conducted toward the use of the
MLAEP latency to control closed-loop anesthesia. Many studies that do have
MLAEP in anesthesia only study the influence that anesthesia has on MLAEP
and not necessarily the correlation of the amount of anesthetic administered to
the patient and the change in MLAEP and their latencies [65], [66], [107]–[109].
Additionally, there is little to no literature that uses the MLAEP latency as a
control variable in a closed-loop control system.
With the Nb trough latency as the measurement signal from the patient,
the trough can be correlated to the plasma concentration in the patient with
help from the results in [66]. This paper uses the MLAEP measured from
paediatric anesthesia to draw up correlations between the various MLAEP
peaks and troughs, and the propofol plasma concentration Cp. These latencies
measured include the Pa, Na, Nb and P1 peaks and troughs, as mentioned in
Section 2.5.3.
It is important to note that the study in reference [66] was conducted on
children. Children and healthy adults have different PK models and character-
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istics and this could pose a problem when attempting to use the same data to
relate Cp to MLAEP latencies in healthy adults. Kuhnle [66] does cite similar
studies conducted on adults, but unfortunately the results from those papers
[110], [111] do not correlate the Cp to MLAEP latencies, as needed here.
The issue with reference [110] is that the measurements are taken at various
stages in the induction and maintenance of anesthesia, and there is inter-
patient variability when it comes to the time at which these various stages of
anesthesia are reached. In reference [111], propofol is not used and different
anesthetic drugs will have different PK characteristics. Therefore, there is no
proper data available to generate the relation between Cp and MLAEP latency
for healthy adults. For these reasons, the system was designed using paediatric
patients.
4.3.4.1 Cp-to-latency
Data from Kuhnle [66] are used to define logistic functions, to establish a
relation between Cp and MLAEP latency
Unfortunately, the details of the lines of best fit from Kuhnle [66] have not
been disclosed, therefore the logistic functions needed to be estimated. From
the line of best fit from the Cplasma vs Peak Nb graph in Kuhnle [66], a couple
of assumptions needed to be made. The value of the latency at 0 µg.ml−1 is
assumed to be 55 ms and the upper limit of the logistic equation is assumed
to be 99 ms. One more assumption made is that the plasma concentration at
63 ms is 3 µg.ml−1.
Using these assumptions, the logistic function can be estimated by using
a basic sigmoid function with two parameters commonly used for subitizing





with L as the height of the sigmoid function, k as the slope of the sigmoid
function, x0 as the x−value of the mid-point and c as the f(x)-intercept, or
the latency when the plasma concentration is 0. The sigmoid function used in





Lastly, the simulated system considers the intra-ear electrode and monitor
as a simple pass-through block between the the patient model and the Cp-to-
latency block.
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4.3.4.2 Latency-to-Cp
The logistic function (4.3) is used to convert the plasma concentration to
latency. For the reference, the inverse of the function is used, to convert the
reference latency to the reference plasma concentration needed by the MPC.
This inverse function, computed from (4.3), is therefore:
x(f) =
−log( L




f−55 − 1) + 6
1.5
(4.4)
With these correlations of the MLAEP latencies and Cp, we can convert
the latencies acquired during anesthesia, to the corresponding Cp.
The contents of the Latency-to-Cp block are depicted in Figure 4.4. Both
f(u) blocks contain the equation (4.4). The top block converts the measure-
ment latency to a measurement Cp and the bottom block converts the reference
latency to the reference Cp.
Figure 4.4: The contents of the block Latency-to-Cp (Inverse of Cp-to-Latency)
in Figure 4.2
4.3.5 Anesthetic amount
The block Anesthetic amount is used to calculate the amount of simulated
anesthetic administered to the patient during the simulation. The contents of
the block is depicted in Figure 4.5.
The manipulated variable, which is the output of the MPC, is the anes-
thetic infusion rate in mg.min−1. The block Anesthetic amount takes this
output and firstly, divides the infusion rate by 60 to determine the infusion
rate in mg.sec−1. The block then integrates that value to get the quantity of
anesthetic administered to the patient.
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Figure 4.5: The contents of the block Anesthetic amount
In a practical system, this block could be used to interface the MPC output
and the infusion pump and it would drive the infusion of the anesthetic pump.
4.3.6 Noise disturbance
It is likely that such a system would encounter some measurement noise. To
account for it, a noise disturbance block was added to the main Simulink model.
The noise disturbance block contains a band-limited white noise generator.
Adding the noise disturbance directly to the measured latency of the Simulink
model causes a major problem for the control loop. The latency in (4.4), f in
this case, cannot be 55 ms or smaller for two reasons: a latency of 55 ms would
cause the fraction to become undefined because c, being the f(x)-intercept of
(4.3), is 55 and any value smaller than 55 ms would cause force the equation
to take the logarithm of a negative number, which would also be undefined.
To account for this, a saturation block has been added to the input of the
Cp-to-Latency block. To prevent (4.4) from becoming undefined, the block’s
lower limit has been set as 55.1 ms, which represents a plasma concentration
of 0 µg.ml−1.
For the design of the system, the band-limited white noise generator will
remain inactive.
4.3.7 System step response
The aim of the design is to control the delivery of an anesthetic to a patient
for the maintenance phase of anesthesia. The system would need to keep the
patient’s plasma concentration at a desired level and that level must be reached
as fast as possible without any overshoot in the step response.
Using the information stated above, the step-response of the average pa-
tient can be generated. Figure 4.6a depicts the latency step-response of the
patient and Figure 4.6b shows the corresponding plasma concentration step-
response. As depicted, the system’s step response satisfies the requirements
stated above.
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(a) Step response of the Nb trough latency
(b) Step response of the plasma concentration
Figure 4.6: Step response of the system on the average patient
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Comparing the MPC and PID
controller
In this section, the MPC closed-loop controller, described in Section 4.3, is
compared to a closed-loop controller using a PID control block. The practi-
cality of using either control block is analysed in this section. The patient
population that was used in the simulations was based on the patient pop-
ulation from [66] and the table of the patient population with all the corre-
sponding Paedfusor PK-model parameters is listed in Table 5.1. The control
loops were designed to reach the reference value as quickly as possible while
not overshooting the reference value.
5.1 MPC
Figure 5.1 shows the performance of the MPC block over the patient pop-
ulation. The MPC controller design is based on the average patient in the
patient population and the results of the design are depicted in Figure 5.1 and
Figure 5.2 labelled as "Latency: Design standard" and "Cp: Design standard",
respectively.
As seen from Figure 5.1, the step responses of the patients vary according
to the patient’s age. Patients that are younger than the average patient of 8.6
years overshoot the reference latency of 63 ms, and as expected, they overshoot
the reference plasma concentration of 3 µg.ml−1. This shows that the design
criteria needs to be adjusted to accommodate inter-patient variability.
Patients that are younger than the average patient tend to overshoot the
reference value because younger patients’ pharmacokinetics are more aggres-
sive than those of older patients. This is because of the smaller volumes used
in younger patients’ compartmental models in conjunction with the same rate
transfer constants used for all the patients in the Paedfusor PK model. The
system can be adjusted to accommodate the younger patients by setting the
controller to be more robust. This would increase the settling time of the
49
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Figure 5.1: Patient latencies from the MPC control loop (in ms)
Figure 5.2: Patient plasma concentrations from the MPC control loop (in
µg.ml−1)
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system’s step response, but it would accommodate a wider variety of patient
variability to keep from overshooting the set-point.
5.2 PID
To design the PID controller, a discrete-time two-degree-of-freedom PID con-
troller was chosen. The controller parameters were designed using MATLAB’s
PID Tuner, as shown in Appendix D, which automatically calculates the ap-
propriate proportional, integral and derivative terms based on a model of the
plant specified, as well as the required step response which the user designs
based on the user’s desired response time and transient behaviour [113].
The tuner determines the controller output by applying the P, I, and D
parameters independently, and the controller output, u, is implemented as:
u = P (b r − y) + I · Ts
1
z − 1
(r − y) +D N
1 +N · Ts 1z−1(c r − y)
(5.1)
with P , I and D as the proportional, integral and derivative gains, z as the
discrete-time time step, r as the reference signal, y as the measured output, N
as the derivative filter coefficient, b as the proportional setpoint weight, and c
as the derivative setpoint weight [114].
The control loop used for the PID controller simulation is depicted in Figure
5.3 and was designed based on the patient population’s average patient and
the results of the design are depicted in Figure 5.4 and Figure 5.5 labelled
as "Latency: Design standard" and "Cp: Design standard", respectively. The
same control criteria were used to design the PID controller: to reach the
reference value as quickly as possible while not overshooting the reference
value.
Figure 5.3: Simulink model for the PID controller
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Figure 5.4: Patient latencies from the PID control loop (in ms)
Figure 5.5: Patient plasma concentrations from the PID control loop (in
µg.ml−1)
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Using the automatic tuner in the MATLAB PID Tuner, a system response
with no overshoot was unattainable. The system was therefore designed with
the least amount of overshoot attainable and the shortest possible settling time.
This was achieved by designing the PID controller block with the following
parameters:








From Figure 5.4, the inter-patient variability also depends on the age of
the patient relative to the average patient. Patients younger than the average
patient have lower overshoots and quicker settling times when compared to
the average patient. This is also because of the smaller compartment volumes
used for the younger patients’ models, so their pharmacokinetics reach steady
state quicker. Patients that are older than the average patient have greater
overshoots and longer settling times. This is true except for the last two
patients, whose settling time is longer, but the overshoot is lower than that of
the average patient.
5.3 MPC compared to PID
To get a better understanding of the differences in the PID and MPC con-
trollers on the system, both system’s step responses and execution times are
compared to determine which controller is more fitting to implement.
5.3.1 Step response comparison
To compare the performance of the MPC and the PID, the latency and Cp
design standards were plotted together to compare their step responses. The
comparison of "Latency: Design standard" are plotted in Figure 5.6 and the
"Cp: Design standard" comparisons plotted in Figure 5.7.
From the plasma concentration comparison in Figure 5.7, it can be identi-
fied that the MPC has a faster step response and no overshoot. The PID step
response has a slower settling time and overshoots the reference 3 µg.ml−1 to
a maximum of 3.04 µg.ml−1. This would make the MPC controller a better fit
for the system because it reaches steady state faster and more safely because
of no overshoot.
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Figure 5.6: Comparison of the simulated latencies of the MPC and PID con-
troller (in ms)
Figure 5.7: Comparison of the simulated plasma concentrations of the MPC
and PID controller (in µg.ml−1)
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5.3.2 Execution time comparison
To determine which system would be more resource intensive, the two control
systems’ execution times were also recorded for the simulated patients over
a 2000 second window. Simulink, as a model-based design and simulation
software package, is not optimized for real-time simulations, so it does not
run the simulation for the duration specified in the design. Rather, Simulink
uses interpreted code and simulates the specified simulation duration [115].
The execution times of each patient’s simulation based on how long it took to
simulate 2000 seconds of processing is tabulated in Table 5.3.
Table 5.3: Execution times for all 14 patients according to the MPC or PID
controller used
MPC [s] PID [s]
Patient 1 8.926 5.497
Patient 2 5.436 6.906
Patient 3 5.641 6.026
Patient 4 6.473 5.110
Patient 5 8.534 5.238
Patient 6 4.853 5.221
Patient 7 4.195 7.299
Patient 8 3.880 5.833
Patient 9 8.281 5.040
Patient 10 10.259 5.038
Patient 11 10.433 5.685
Patient 12 4.921 5.222
Patient 13 8.106 5.107
Patient 14 4.941 6.452
Average 6.777 5.691
For the MPC control loop, the average execution time was 6.777 s and
the PID controller control system executed for an average time of 5.691 s.
The data also indicates that the PID controller remains more consistent in
controlling infusion of the different patients with varying PK models. This
indicates that the PID system would be less resource intensive in a practical
setting as it does not need as much processing power to execute the control
loop as the MPC controller would need.
From the data gathered from both the MPC and PID controllers, it would
be fair to conclude that the MPC controller is the more suited controller to use
in this setting. Despite the fact that the MPC requires more processing power
to operate than the PID, it is more appropriate for this setting because of its
faster settling time and no overshoot. This would help for a more seamless
transition from the induction to the maintenance phase of anesthesia.
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5.4 Changing the reference
Changing the reference of the closed-loop control system would change the
plasma concentration which the system would aim to achieve in a patient. This
in turn would change the plasma concentration experienced by the patient.
5.4.1 Background
In anesthesia, it is not uncommon for the anesthesiologist to alter the depth
of anesthesia experienced by the patient. One of the main reasons for altering
the amount of anesthetic delivered to a patient, and subsequently deepening
the level of anesthesia experienced by the patient, is to avoid awareness during
anesthesia. Awareness occurs when too little anesthetic is delivered to the
patient’s brain and the patient remains conscious. Total intravenous anesthesia
(TIVA) systems are designed using the pharmacokinetics of the average of
a certain patient population [37]. It will, therefore, be incorrect to assume
that the system’s internal PK model can cater adequately for a larger patient
population.
For example, the anesthesiologist can administer the mandatory amount of
anesthetic and notice that the patient exhibits signs of consciousness because
of signs like movement or hyperactive haemodynamics, or the patient shows
signs of drug resistance because of prior experience of awareness, excessive
alcohol use or the use of amphetamines, cocaine or opiates [116], which would
lead the anesthesiologist to increase the level of anesthetic delivered, to ensure
an adequate depth of anesthesia. Providing "light anesthesia" to a patient can
be intentional. Surgeries like cardiac, obstetric or paediatric surgery require
the anesthesiologist to intentionally administer light anesthesia because of the
adverse effects that anesthetics can have when coupled with severe bleeding,
septic shock and possible cardiac arrest [116].
5.4.2 System design
For these reasons, the system should be able to alter the level of anesthesia
when the anesthesiologist deems it necessary. The Simulink model has been
modified by adding a block that introduces the ability to modify the refer-
ence plasma concentration and is depicted in Figure 5.8. The system has an
added summation block and the block "Changes to the Reference Cp" which
includes a signal builder, depicted in Figure 5.9. The signal builder is the block
that will be used to generate the various alterations to the reference plasma
concentration.
To simulate changes in the level of anesthesia experienced by a patient,
the reference plasma concentration was altered according to the regime set by
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Figure 5.8: Simulink model of the changing reference simulation
Figure 5.9: Signal builder block in the changing reference simulation
the signal builder. The alterations are depicted in Figure 5.10. The regime is
listed below:
Table 5.4: Changing the plasma concentration as depicted in Figure 5.10
Time Period Alteration [µg.ml−1] New Cp [µg.ml−1]
0 s - 500 s - 3
500 s - 1000 s + 0.2 3.2
1000 s - 1500 s + 0.4 3.6
1500 s - 2000 s - 0.6 3
2000 s - 2500 s - 1 2
2500 s - 3000 s - 0.5 1.5
5.4.3 Results
To draw comparisons between the controller performances, MPC and PID
controllers were simulated with changes to the reference plasma concentration
for the simulated patient population. The plasma concentration results from
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Figure 5.10: The reference signal generator for the "Changes to Reference Cp"
block in the Simulink model
the MPC controller simulations are depicted in Figure 5.11, and the results
from the PID controller simulations are depicted in Figure 5.11.
Figure 5.11: Plasma concentrations of the patient population with the MPC
controller with changes to the reference plasma concentration
To compare the performances of both controllers, the MDPE, MDAPE and
wobble of the simulations were calculated. The simulated patient populations’
MDPE, MDAEP and wobble are compared in Figures 5.13a, 5.13b and 5.13c,
respectively.
As mentioned in , MDPE represents the bias of a controller’s performance,
with a positive MDPE representing the controller’s performance being above
the reference value and a negative MDPE representing a controller’s perfor-
mance being below the reference value. The MDAPE represents the magnitude
of the error between the reference value and the measured value. Lastly, the
wobble represents the oscillations of the controller and it measures the intra-
subject variability in the measurements.
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Figure 5.12: Plasma concentrations of the patient population with the PID
controller with changes to the reference plasma concentration
Figure 5.13a depicts that the PID controller has a tendency to overshoot
the reference value than the MPC controller. This depicts that the PID con-
troller is more likely to overdose the anesthetic administered than the MPC
controller. The MDPE of the MPC controller shows that it would underdose
the anesthetic for some younger patients, and overdose the anesthetic for some
of the older patients.
The MDAPE in Figure 5.13b depicts that the PID controller has greater
errors in the control performance than the PID. This shows that in more
control operations, the PID controller does not follow the reference value as
closely as the MPC controller does.
Lastly, the wobble of the PID controller is generally greater than that of the
MPC controller. This depicts that the PID controller has greater oscillations
in its control of the simulated patients’ plasma concentration. This, combined
with the greater MDAPE of the PID controller, shows that the PID controller
could be less stable than the MPC controller in administering anesthetic, which
could be potentially dangerous to the patient.
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(a) MDPE of the simulated patient population for the MPC
and PID controller
(b) MDAPE of the simulated patient population for the MPC
and PID controller
(c) Wobble of the simulated patient population for the MPC
and PID controller
Figure 5.13: Performance error comparisons of the MPC and PID controllers
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Chapter 6
Simulations based on possible
application scenarios
This chapter expands on the design of the MPC control loop and analyses the
effect of measurement noise that could be encountered during the maintenance
phase of anesthesia that the system would need to make provision for.
6.1 Measurement noise
To simulate the influence of measurement noise on the system, the band-
limited white noise block in the Noise disturbance block, depicted in Figure
4.2, is activated to add noise to the measured latency.
6.1.1 Background
To determine the magnitude of the noise levels to be added to the system,
signal-to-noise ratios (SNR) were used. SNR is defined as the ratio of the
power of a desired signal relative to the power of the noise within the signal
[117]. It can be described as a unit-less ratio, or more commonly, it can be
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6.1.2 Simulation design
To simulate the measurement noise scenarios, the band-limited white noise
generator within the Noise disturbance block in Figure 4.2 was activated and
used.
The power of the reference latency signal from the simulation over 500












with N as the total number of samples in a 500 second window, n as the
sample number and x(n) as the step function that is the reference latency.
The power of the reference latency was calculated as 15 dB. The SNR values
used to simulate the added noise were 40 dB, 30 dB, 20 dB, 15 dB, 10 dB, 5
dB, 0 dB and -3 dB.
6.1.3 Results
The latency results with added measurement noise are depicted in Figure 6.1,
and the corresponding plasma concentration results are depicted in Figure 6.2.
The MDPE, MDAPE and wobble of the measurement noise simulations are
depicted in Figures 6.3a and 6.3b. These performance characteristics depict
that as the measurement noise increases, the bias and the magnitude of the
error of the controller performance increases.
From the performance error characteristics in Figure 6.3b, it is clear that
the influence of measurement noise experienced by the system remains rela-
tively consistent below 10 dB and it starts increasing relatively linearly from 5
dB, therefore the system would be more stable if the noise input to the system
was limited to about 15 dB.
From reference [37], the maintenance plasma concentration of propofol in
children should range between 2 µg.ml−1 and 4 µg.ml−1 for cases lasting longer
than 30 minutes and when an opioid is given alongside. From the results, all the
noise ranges remain within those thresholds, except the plasma concentration
of the -3 dB case. From analysing the noise simulation results as well as Figure
6.3b, the maximum acceptable signal to noise ratio is chosen as 15 dB. The
plasma concentration in that scenario ranges from 3.1 µg.ml−1 to 2.9 µg.ml−1,
and the corresponding latency is within the threshold of 66 and 60 ms from
the 63 ms reference.
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(a) Measured latencies with 40 dB
and 30 dB SNR (in ms)
(b) Measured latencies with 20 dB
and 15 dB SNR (in ms)
(c) Measured latencies with 10 dB and
5 dB SNR (in ms)
(d) Measured latencies with 0 dB and
-3 dB SNR (in ms)
Figure 6.1: Measured latencies with added noise
6.2 Final system
This chapter has has elaborated on the various adjustments to the depth of
anesthesia experienced by a patient and the anesthesiologist has the respon-
sibility of making sure that the patient stays comfortable while undertaking
these adjustments. The final system will therefore need to include the var-
ious modifications made to the main system. The final system with all the
modifications is depicted in Figure 6.4.
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(a) Cp with 40 dB, 30 dB, 20 and 15 dB SNR (in
µg.ml−1)
(b) Cp with 10 dB, 5 dB, 0 dB and -3 dB SNR (in
µg.ml−1)
Figure 6.2: Cp with noise added to the measured latency
(a) MDPE values of the noise simula-
tions over the noise range
(b) MDAPE and wobble values of the
noise simulations over the noise range
Figure 6.3: Performance error characteristics for the measurement noise sim-
ulations
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This chapter expands on the results obtained in the preceding chapters. The
focus of this chapter is to place the results, and the entirety of the research
project, into perspective and it expands on how the system could be incorpo-
rated in a surgical setting.
7.1 The system in practice
For the whole system to operate efficiently, a number of components need to
be put together and their compatibility with each other must be tested for
correct operation.
The intra-ear electrodes from the novel intra-ear monitor [10] need to be
fitted into the patient’s ear and then connected to the monitor to read the
signals. The monitor is then connected to the controlling computer through
a wired connection or through the OpenBCI Cyton wireless Bluetooth USB
module [10], [118]. The computer will run the algorithms that extract the
MLAEP from the EEG data as well as send the MLAEP information to the
closed-loop controller.
When the closed-loop controller has calculated the amount of anesthetic
to be infused, it will transmit infusion instructions to the infusion pump. A
digitally-controlled infusion pump will receive the infusion instructions and
control the syringe containing the anesthetic. The anesthetic is then pumped
into the patient and the loop is complete and it can recycle. The control loop
is depicted in Figure 7.1.
67
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Figure 7.1: The implementation of the system in practice
7.2 Overview of general anesthesia with the
closed-loop control system included
General anesthesia consists of 3 phases: induction, maintenance and emer-
gence [3]. To incorporate the closed-loop control system into the practice of
anesthesiology, the routines used to prepare the systems needed to sedate a
patient, as well as routines for the preparation of the patient, will need to be
adjusted. Preparation procedures need to be done separately and thoroughly
to ensure that both the closed-loop control system and normal processes of
anesthesia happen effectively without hindering each other’s performance in
any way.
7.2.1 Preparation
The anesthesiologist will prepare for the procedure as well as prepare the
patient according to the normal pre-anesthesia care and checks used in practice,
similar those mentioned in [37], [119].
During the preparations conducted by the anesthesiologist, the closed-loop
control system would need to be prepared. The anesthesiologist would need
to allow for multiple channels of intravenous infusion to accommodate the
infusion of the anesthetic, opioid and analgesic during the induction phase
[32], and a separate channel would be needed to connect the syringe of the
closed-loop control system’s infusion pump to the patient for the maintenance
phase. This can be achieved by using a multi-lumen connector to accommodate
the numerous lines of infusion, depicted in Figure 7.2 [37]. Each line should
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have anti-reflux and anti-siphon valves to prevent the anesthetic or other drugs
from flowing back into the syringes.
Figure 7.2: An example of a multi-lumen connector with anti-reflux and anti-
siphon valves [37]
7.2.2 Induction
In the induction phase, the anesthesiologist prepares the patient for the anes-
thesia and the surgery by pre-medicating the patient with the desired anes-
thetic. From there, the patient is monitored closely by the anesthesiologist to
determine the depth of anesthesia experienced by the patient.
Once the anesthesiologist deems the patient to be at an appropriate level of
anesthesia, the anesthesiologist will then enter the desired plasma concentra-
tion for the maintenance phase into the closed-loop control system. This level
could vary slightly for different patients because of inter-patient variability.
Then maintenance phase can begin.
7.2.3 Maintenance
The patient will be kept at the desired depth of anesthesia by the system.
The anesthesiologist will not be required to dedicate his/her full attention to
the patient, as the system will be controlling the delivery of anesthetic to the
patient to keep the patient at the specified depth of anesthesia based in the
propofol plasma concentration.
During the maintenance phase, the surgery could require a number of sit-
uations that the system would need to accommodate. The anesthesiologist
could be required to alter the level of anesthesia the patient experiences if the
patient exhibits signs of awareness, like movement or an increasing heart rate,
or the patient could be experiencing a drop in blood pressure [116]. This will
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be done by entering an new reference plasma concentration into the system,
either higher or lower than the previous value, and the system will adjust
accordingly, as described in Section 5.4.
7.2.4 Emergence
Once the surgery is complete, the emergence phase will begin to return the
patient back to consciousness. Anesthesiologists are less likely to switch off an
infusion system at the end of a procedure because the surgeon could still need
to do some work on the patient [120]. Therefore, the anesthesiologist will be
required to decrease the reference plasma concentration to allow the patient
to return to consciousness. This can be done by just setting the controller to
achieve a plasma concentration of about 1.5 µg.ml−1 [37], allowing the patient
to slowly gain consciousness.
7.3 Motion artefacts
Another factor that would be interesting to investigate is the influence of
motion artefacts on the system.
7.3.1 Introduction
Motion artefacts are undesired signals generated in biological systems, which
stem from the movement of one component of the system relative to another
[121]. For this system, the motion artefact to be considered would be caused
by motion between metal, the intra-ear electrode, and the electrolyte, being
the electrode gel on the surface of the external auditory canal, depicted in
Figure 2.3.
7.3.2 Background
The most likely sources of artefacts that could influence the intra-ear system
would be eye movements or muscle activity, such as the movements of the
jaw. Jaw movements are of greater concern with regards to motion artefacts
within the inner ear [122]. Jaw motion can cause changes in the shape of the
ear canal, which would adjust the positioning of the intra-ear electrode. The
motion between the electrode and the electrode gel during that adjustment
would then generate an artefact voltage.
According to [10], the intra-ear monitor will be playing an audio stimulus
in the patient’s ear and from that ear, the AEP will be recorded. The patient
should only register the single stream of audio stimulus to the one ear for
accurate MLAEP information to be recorded from the ear of interest.
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One factor that was considered in the design is mitigating the influence
that bone conduction in the opposite ear would have on the system. Bone
conduction is when vibrations are transmitted through the skull and then
received by the inner ear. These vibrations will then be registered by the
brain as sound [123]. In this case, the audio stimulus in the ear of interest
would be transmitted into the desired ear, as well as through the skull into
the opposite inner ear. There would then be two audio stimuli perceived by
the brain and the brain would respond to both stimuli. To mitigate this, the
system generates white noise into the opposite ear to mask the bone conduction
[10].
7.3.3 Motion artefact simulation
According to [121], artefact voltages (Va) generated between a metal and an
electrolyte can be calculated as:
Va = ∆Q/C
= ∆Q φ/(σ S0)
= [K τ φ/S0] [1− exp(−t/τ)]
(7.1)
with φ, the electrochemical potential [mV ], S0, the total surface area of the
electrode [mm2], and K is the exposed area per unit time [mm2.s−1]. The
parameter τ is the dielectric relaxation time constant [ms], and t is the contact
time of K over a certain area S0 [ms].
To determine the artefact voltages that could potentially plague this sys-
tem, it would be beneficial to simulate the possible voltages that could be
generated. With knowledge of the types of electrodes used in the system,
the parameters S0 and K can be determined. Unfortunately, a couple of the
parameters used to calculate Va can only be determined experimentally [121].
Furthermore, there have been no experiments recorded where the electrochem-
ical potential or the dielectric relaxation time constant of gold and the specific
concentration of sodium chloride (NaCl) in the Ten20 electrode gel, used in
[10], have been recorded. Therefore, it would be hard to simulate the exact
amount of artefact voltage that moving the intra-ear electrode would generate.
However, with these two unknowns, it is possible to plot a 3-dimensional
mesh of the possible artefact voltages that can be determined. The x- and y-
axes can be the two variables, the electrochemical potential and the dielectric
relaxation time constant, and the z-axis will be the artefact voltages possible
from the combination of the x- and y-axes calculated using (7.1).
Some assumptions need to be made because of the number of unknown
variables available. Firstly, the intra-ear electrode is assumed to have the
Stellenbosch University https://scholar.sun.ac.za
CHAPTER 7. DISCUSSION 72
Figure 7.3: Simulated range of artefact voltages
same surface area as the gold-cup electrodes used for the earlobe plugs [10].
Secondly, the EEG recording of the intra-ear monitor only records the EEG
signals once the audio stimulus is generated. Any signals that linger for longer
than this sample time would be filtered out as a DC offset [10], or they could
corrupt the EEG signal measured for the duration of the movement. To cal-
culate a possible minimum Va that could be generated, the motion time of the
electrode is assumed to lie within this sample time of 125 ms [10] and it is thus
simulated at 500 µs.
7.3.4 Results
From Figure 7.3, it is clear to see that under these conditions, artefact voltages
generated will lie between 0 and 10 µV. The MLAEP voltage levels recorded
by the intra-ear monitor lie within the same range after the filtering and aver-
aging algorithms are applied to the raw EEG signals recorded [10], so motion
artefacts will influence the readings of the MLAEP signals for the closed-loop
system. It is likely that unintended jaw movements could occur for a couple
of seconds. So using the 500 µs simulation as a baseline, motion lasting longer
than 500 µs could corrupt a fair amount of Va measurement samples until the
motion stops.
According to [9], anesthesia only shows a clear influence on the delay of
the MLAEP peaks and troughs. The deeper the patient drifts into anesthesia,
the greater the delay. The amplitude of the peaks and troughs do not show
any notable change as the patient drifts deeper into anesthesia.
An example of the MLAEP plot read from the intra-ear system is depicted
in Figure 7.4. In this case, the additional artefact voltage generated would
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slightly increase the amplitude of MLAEP readings at certain points in the
signal. If the artefact were to fall on a trough, the voltage would be increased
slightly, but the system would still be able to identify it as a trough with
respect to the surrounding Pa- and P1-peaks. However, if the artefact were to
fall on any other point, it could make the system miscalculate the latency.
Figure 7.4: An example of the MLAEP signal acquired from the intra-ear
system [10]
Therefore, it would be a good idea to design an algorithm that could detect
and filter out any artefact voltages generated during the reading of MLAEP
signals during anesthesia.
7.4 Advantages of incorporating the system
in practice
There are a number of advantages associated with using such a system in
practice.
7.4.1 Benefits to anesthesiology
As mentioned in [1], there is a great shortage of workers in South Africa’s
healthcare sector and this includes a shortage in anesthesiology. This system
could provide the necessary support needed in hospitals and bridge the gap in
the shortage of anesthesiologists.
Unlike an anesthesiologist, the system is not susceptible to fatigue caused
by the irregularity of an anesthesiologist’s daily schedule and the constant
focus needed from the anesthesiologist during lengthy surgeries [1]. It is able
to provide consistent, accurate doses of anesthetic regardless of the number of
hours it has to maintain a patient in anesthesia. Once the anesthesiologist has
administered the required induction procedure, the system can then take over
the maintenance phase and the anesthesiologist is only needed to oversee the
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administration of anesthetic from the system and intervene when necessary.
This does not demand as much focus from the anesthesiologist and can possibly
be done from a separate control centre or from a smart device.
With this newly found freedom, the anesthesiologist could administer the
induction phase to another patient and set up the closed-loop control system
to control the delivery of anesthetic during the maintenance phase to each
patient. Once the maintenance phases begin, the anesthesiologist could oversee
this number of patients from a control room that gives information on each
procedure, and the MLAEP latency measured from the patient through each
system could alert the anesthesiologist if there is a need for an intervention in
any of the procedures. This allows for fewer anesthesiologists to be needed in
a single hospital and the anesthesiologists available could be distributed more
evenly across the South African population.
7.4.2 Wider usability
Additionally, the system can be operated by an individual with lower qualifica-
tion than an anesthesiologist. Since the setup of the system and the sedation
of the patient will primarily be handled by the anaesthesiologist, the indi-
vidual with the lower qualification can take over when the patient enters the
maintenance phase. What is important is that the anesthesiologist should still
have higher-level oversight over the system in the control room. This would
allow for quick, on-site recognition and resolution of issues that the user might
encounter with the system or the patient.
7.5 Concerns of using the system in practice
Before the system is tested and implemented in practice, a couple of concerns
need to be addressed.
7.5.1 Thorough testing is needed
The system would need to be tested rigorously through animal tests as well as
to be tested on live patients to make sure that the system works adequately.
The system was designed using the Paedfusor PK model, so the system can
initially only be used in paediatric anesthesia.
The system would also need to be reviewed by various anesthesiologists to
determine if it works to the satisfaction of the various anesthesiologists and
boards of approval. With their support, the system could be be rolled out and
used in numerous hospitals with confidence based on the accreditation from
the various anesthesiologists and the necessary boards required to implement
such a system, like the South African Society of Anesthesiologists.
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As mentioned in [120], anesthesiologists are not very familiar with the use of
plasma concentration in monitoring depth of anesthesia. This could be because
there are no measures of anesthetic plasma concentration available to be used
in medical settings. Anesthesiologists have a better knowledge of the effect
that a certain amount of infused anesthetic will have on a patient, rather than
the influence on the plasma concentration that the infused anesthetic will have.
Therefore, anesthesiologists will have to be familiarized with the influence of
plasma concentration on the depth of anesthesia a patient experiences, or the
system will need to be used with a general guide describing the influence that
various plasma concentrations have on a patient.
7.5.2 Processing power
For the whole system to operate efficiently, the processing power of the various
components needs to be sufficient. The concatenation of the intra-ear monitor,
controller PC and the digitally-controlled infusion pump, which would need to
be built specifically to work with this system, would need to be compatible with
each other to deliver the necessary dose of anesthetic to the patient timeously.
The processing power of the controlling PC is of greatest concern in this
case because it will be running software filtering the MLAEP data from the raw
EEG streamed from the intra-ear monitor [10] and the whole control system
and if it does not process the information it transmits and receives timeously,
it can delay the whole loop and the patient will not receive the correct dose
of anesthetic. The average dosing sampling time of 10 seconds [37] should
be sufficient for the the whole process to run its cycle before the next dosage
required, but it would need to be thoroughly tested to ensure that the whole
process can be completed within the sampling interval of 10 seconds.
If it is found in a particular setting that the implementation cost of the
MPC closed-loop control system is too high because of the increased processing
power required, the PID closed-loop control system can be considered as a more
affordable alternative. As shown in Section 5.3, although the PID controller
has a slower settling time and a larger overshoot, the infusion algorithm runs
faster. The overshoot of the system’s step response does also fall within a
usable range according to [37] as it states that the plasma concentration needed
during the maintenance phase of anesthesia ranges between 2.5 and 4 µg.ml−1.
7.5.3 Measurement noise
If the closed-loop control system were to be operated in an environment sus-
ceptible to noise, it would be beneficial if the noise were capped at SNR of
15 dB as mentioned in Section 6.1. However, if the SNR was to drop below
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15 dB, a noise filter may need to be incorporated into the system. The fil-
ter would need to raise the SNR to 15 dB or higher, as described in Section
6.1. The filter would need to be added to the feedback path, after the latency
measurement is recorded and before by the "Latency-to-Cp" block in Figure
6.4.
7.6 Limitations
A major limitation in the implementation of the system is related the patient
population that would benefit from this system. The reason the Paedfusor
model was used in the design is that the look-up tables relating the MLAEP
latencies to the propofol plasma concentrations, depicted in [66], are not avail-
able for the other PK models used in practice, like the Schnider and Marsh
models.
To incorporate other PK models, further research and tests need to be
conducted into finding the correlation between the plasma concentration and
MLAEP latencies for the patient populations that make up the other PK
models. With this information, correlations similar to those in [66], and the
corresponding functions, like that in Equation (4.3), can be determined. These
correlations could then be used in conjunction with the corresponding PK
models used for adults, like the Schnider, Marsh and Eleveld PK models,
within the MPC controller. From there, the system could be further developed
for use with adults.
Additionally, without definite information about the data points in [66], the
estimated sigmoid function in (4.3) and its inverse in (4.4) will vary according
to the estimations made by the users of the information. Further tests would
need to be conducted to acquire more data so establish industry-standard
correlations of the plasma concentration and latencies.
7.7 Possible additions to improve the system
Using these findings and this design of this system as a springboard, there are
a number of additions that can be investigated to improve the system.
7.7.1 Prototyping
Prototyping is the natural next step for the system. Before tests are conducted
using the system, a digitally-controlled anesthetic infusion pump needs to be
built for the control system. The advantage of building an infusion pump
is that the infusion pump will be driven through instructions given from the
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closed-loop control system, directly. The infusion pump can also be built ac-
cording to specifications which satisfy the needs of the anesthesiologist and the
specific test case used for testing the system. It can also be a more affordable
alternative to the infusion pumps that are on the market [124].
The block Anesthetic amount, mentioned in Section 4.3.5 can be adapted
to drive the infusion pump. This would be done by translating the amount of
anesthetic infused to the the distance the syringe’s plunger needs, depicted in
Figure 7.5, to move to administer the specified amount of anesthetic required.
Figure 7.5: Diagram of a syringe [125]
To account for the transition speeds that the anesthetic infusion pump
would capable of for situations such as those in Section 5.4, the MPC block
would need to be adjusted. The MPC includes constraints that specify the
maximum and minimum rate of change of the manipulated variable. This
would be beneficial to include in the MPC for the system to account for the
capabilities of the anesthetic infusion pump as it will have maximum speed
specifications.
There should also be a user interface developed for easy control of the
whole system. This user interface would be responsible for the input of the
plasma concentration required for the maintenance phase and the adjustment
of the selected plasma concentration. It would also be used to indicate that the
infusion is in progress and used to monitor the current MLAEP latency and
plasma concentrations read from the patient. Additionally, the user interface
could also display other information like the patient’s heart rate and breathing
rate to get a holistic view of the patient during anesthesia on one display.
The system will then need further additions to alert the anesthesiologist
about the state of the infusion pump. These additions will could include adding
default alarms for situations in which the infusion has stopped because: the
end of the procedure has been reached or the syringe has been disconnected
from the multi-lumen connector; the syringe is running out of anesthetic or is
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empty; the main power supply has been disconnected or the stand-by battery
is running low [37].
7.7.2 Using other vital signs available in the inner ear
It has been found that from the inner ear, other vital signs can be acquired
alongside MLAEP. These include heart rate, heart rate variability, blood oxy-
genation levels, body temperature and respiratory rate [126]. The availability
of these other vital signs pave the way for the closed-loop control system to be
adapted to administer other drugs. Provided that the PK model of the drugs
to be infused is available, the system can be adapted to infuse a variety of
drugs other than propofol.
General anesthesia involves the administration of drugs for hypnosis, to
provide: unconsciousness; analgesia, for pain suppression; and neuromuscular
blocking drugs, to prevent movement during surgery [34]. By using the re-
lationship between heart rate variability and the sensation of pain a patient
experiences [127], a separate closed-loop control system can be developed to
administer an analgesic during general anesthesia.
Depending on the processing power of the available controller, these various
closed-loop control systems could be incorporated into one machine and the
system could operate as a multi-input multi-output (MIMO) system. This
means that the various measurements read from a single patient could be read
into the one machine. The machine would then collect the measurements and
assigns them to their appropriate controllers and each controller sends output
signals to the appropriate infusion pump to administer the correct amount of
drug to the patient.
7.7.3 Further developments to accommodate the
induction phase
The system could also be improved by designing it to also administer drugs for
the induction phase. This is a more involved stage in anesthesia because the
anesthesiologist administers the drugs at specific quantities and monitors the
patient’s response to those doses until the patient is deemed fully anesthetized
and ready to begin the maintenance phase of anesthesia.
As mentioned in [10], the intra-ear monitor has a built-in accelerometer
and it measures accelerometer data in three axes. These measurements could
be used to monitor the movements of the patient while the system administers
the appropriate doses of anesthetic for the induction phase. Alongside the
movement of a patient, the system could also incorporate other vital sign
information, like heart rate and breathing rate [116]. If the anesthesiologist
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deems the measurements taken adequate for a fully anesthetized patient, the
system could then switch into "maintenance phase mode".
The infusion regime conducted for the induction phase differs from that of
the maintenance phase, therefore multiple MPC controllers could be applied
to allow for the different control sequences of the two phases.
7.7.4 Machine learning implementation
Furthermore, there may be potential for a machine learning implementation of
the system. Machine learning is the automatic detection of patterns in large
amounts of data and from the patterns that have been determined, future
predictions can be made on new data introduced or other decision making
processes can be executed [128].
Since the induction phase is more involved because of the inter-patient
variability involved in sedating the patients adequately and the anesthesiologist
needs to keep a close eye on how the patient responds to the drugs being
administered, it would be interesting to investigate the patterns that a number
of patients exhibit when undergoing the induction phase so that the machine
learning algorithm could implement the anesthetic infusion regime required to
sedate a patient during the induction phase.
To train the machine learning algorithm, it would need to collect plenty
of training data consisting of a number signals from many patients as they
undergo the induction phase. The algorithm would need to be trained on
the data from patients’ vital signs and, potentially, anesthetic plasma con-
centrations as patients are sedated. Once thoroughly trained, the algorithm
would then administer anesthetic to a patient during the induction phase to
adequately sedate a patient from the induction phase and once acceptable





From previous work, it has been shown that it is possible to determine the
depth of anesthesia a patient experiences by monitoring the patient’s EEG
signals [38]. From the EEG signals, the auditory evoked potentials can be
derived and they correlate well with the depth of anesthesia experienced [7].
The latency of the MLAEP signals tends to increase as the patient experiences
deeper levels of anesthesia. It has also been discovered that these signals can
be acquired inside the patient’s ear as a non-invasive form of signal acquisition
[10], [45].
Using this information, a closed-loop control system has been designed that
is able to keep a simulated patient adequately sedated. The closed-loop control
system uses the latency of the of the MLAEP’s Nb-trough to determine the
plasma concentration of propofol within the patient. If this plasma concentra-
tion falls below that specified by the anesthesiologist, the system will increase
the infusion of propofol to the patient. When the desired latency or plasma
concentration is reached, the system is designed to monitor and maintain the
plasma concentration at that specified level.
From the simulations, it has been shown that the MPC controller is a better
controller to use for the closed-loop control of anesthetic delivery compared to
the PID controller because of its faster settling time and its ability to suppress
the step response’s overshoot better than the PID.
Additionally, the MPC control system has shown that it is capable of ade-
quately manipulating the plasma concentration within a simulated patient to
alter the depth of anesthesia experienced by managing reference value changes.
This is done without overshooting the new plasma concentration set during
the process.
The simulations conducted have shown that the SNR experienced can be
quite low, yet the system is robust enough to maintain a plasma concentration
between the desired values of 2-4 ug.ml−1 [37]. To keep the deviation of the
plasma concentration as low as possible, it would be best to keep the SNR to
a minimum of 15 dB.
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Motion artefacts have been shown to have a potential influence on the sys-
tem and could cause problems in the operation of the system. If the electrodes
were to move during operation, they would introduce artefact voltages to the
system that could corrupt sections of the MLAEP measured. Measures would
need to be investigated to mitigate the influence of motion artefacts if they are
shown to have an influence on the MLAEP readings of the system in practice.
8.1 Review of research questions
The tests and simulations in this thesis were conducted in an attempt to answer
the research questions stated in Section 1.5. The research questions will then
be individually addressed below.
8.1.1 Closed-loop control interfacing intra-ear
monitoring and general anesthesia
Based on the simulations performed, closed-loop control can be used to inter-
face intra-ear monitoring and general anesthesia. A model predictive controller
(MPC) has shown to perform adequately for this application because it allows
for the incorporation of a patient model within its control algorithm. With
the patient model incorporated and the the performance criteria specified,
the controller’s step response is able to achieve a short settling time with no
overshoot.
8.1.2 MLAEP latencies used as a control signal
There is currently no ubiquitous method to measure the anesthetic plasma
concentration. It has, however, been found that MLAEP signal latencies corre-
late well with the concentration of anesthetic within a patient [66]. Therefore,
MLAEP latencies have shown to be appropriate control signals.
8.1.3 System usability with a wide range of patients
The usability of the closed-loop control system is currently limited to paediatric
patients in general anesthesia because of the limited research in the correlations
of the MLAEP latencies and the anesthetic plasma concentration in other
patient populations.
Based on the simulations conducted, the system is able to keep a wide range
of simulated paediatric patients adequately sedated despite the wide range of
inter-patient variability in anesthesia. The MPC controller would need to be
made more robust to account for the rigorous pharmacokinetics of younger
patients.
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8.1.4 The anesthesiologist’s user requirements
The system has been designed with an idea of the actions that the anesthesi-
ologist might want to undertake during the maintenance phase of anesthesia.
The system has shown that it is able to steadily change the simulated pa-
tient’s plasma concentration to that set as the system’s reference during the
simulated maintenance phase. This can be used to increase the plasma con-
centration, deepening the anesthesia experienced, or lightening the anesthesia
by decreasing the reference plasma concentration.
8.2 Future work
Using this work as a springboard, there is research to be conducted that could
advance this system. The system could enter a prototyping phase to test the
system’s usability in animal tests first, and then in paediatric anesthesia. Fur-
ther research could be conducted to acquire the necessary MLAEP latency and
plasma concentration correlation to make the system available to wider range
of patients. The system could also be adapted to a administer other drugs
used in surgery. Lastly, further research could be conducted to improve the
system’s capability to administer the induction phase of anesthesia. Provided
that sufficient data could be collected, a machine learning-based implementa-
tion could be undertaken. A machine learning-based implementation would
be beneficial as it may allow for the automation of the induction phase of






Notes from the private








B.1 Average patient PK model initialization
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1   % PK SIMULATION 2   3   age = 8.6;4   weight = 29.2;5   6   7   if age >= 0 && age <= 128   V1= 0.4584 * weight;9   k10 = 0.1527 * weight.^(-0.3);10   11   elseif age == 1312   V1 = 0.400 * weight;13   k10 = 0.0678;14   15   elseif age == 1416   V1 = 0.342 * weight;17   k10 = 0.0792;18   19   elseif age == 1520   V1 = 0.284 * weight;21   k10 = 0.0954;22   23   elseif age == 1624   V1 = 0.22857 * weight;25   k10 = 0.119;26   end27   28   k12 = 0.114;29   k13 = 0.0419;30   k21 = 0.055;31   k31 = 0.0033;32   ke0 = 0.26;33   34   V2 = V1 * k12/k21;35   V3 = V1 * k13/k31;36   
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B.2 Paediatric patient population PK model
initialization
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1   % RANDOMIZED PAEDIATRIC PATIENT POPULATION2   3   paed = struct('age', age, 'weight', weight, 'height', 125.9);4   5   % Random patient generator6   % x = sd*randn(range, 1) + mean7   8   % ages = 4.3*randn(14, 1)+8.69   ages = [18.7070, 5.9529,11.8167,7.7726,12.4210,5.3111,10   2.5702,2.4838,10.6992,7.8373,7.7570,14.7030,11   9.8538,9.4506];12   % weights = 14.6*randn(14, 1)+29.213   weights = [36.9395,15.2998,41.6690,34.8815,12.3224,14   29.7802,22.6213,30.7950,25.5419,26.4274,15   14.1195,24.4799,40.3913,54.6722];16   % heights = 26.2*randn(14, 1)+125.9;17   heights = [95.4944,188.1882,165.8832,130.3149,18   118.0084,107.5953,147.7186,107.7013,19   113.7987,149.0508,137.3217,149.3948,20   139.1240,115.3965];21   22   23   ages = sort(round(ages));24   weights = sort(weights);25   heights = sort(heights);26   27   paed.age = ages;28   paed.weight = weights;29   paed.height = heights;30   31   age_data = zeros(1, 14);32   height_data = zeros(1, 14);33   weight_data = zeros(1, 14);34   V1_data = zeros(1, 14);35   V2_data = zeros(1, 14);36   V3_data = zeros(1, 14);37   k10_data = zeros(1, 14);38   k12_data = zeros(1, 14);39   k21_data = zeros(1, 14);40   k13_data = zeros(1, 14);41   k31_data = zeros(1, 14);42   ke0_data = zeros(1, 14);
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B.3 Paediatric patient population PK model
initialization
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1   % PK SIMULATION 2   % n = 1; % Patient number in sturct3   4   age = paed.age(n);5   weight = paed.weight(n);6   height = paed.height(n);7   8   9   if age <= 1210   V1= 0.4584 * weight;11   global k1012   k10 = 0.1527 * weight.^(-0.3);13   14   elseif age == 1315   V1 = 0.400 * weight;16   global k1017   k10 = 0.0678;18   19   elseif age == 1420   V1 = 0.342 * weight;21   global k1022   k10 = 0.0792;23   24   elseif age == 1525   V1 = 0.284 * weight;26   global k1027   k10 = 0.0954;28   29   elseif age >= 1630   V1 = 0.22857 * weight;31   global k1032   k10 = 0.119;33   end34   35   global k1236   k12 = 0.114;37   global k1338   k13 = 0.0419;39   global k2140   k21 = 0.055;41   global k3142   k31 = 0.0033;43   global ke044   ke0 = 0.26;45   46   V2 = V1 * k12/k21;47   V3 = V1 * k13/k31;48   49   age_data(n) = age;50   height_data(n) = height;51   weight_data(n) = weight;52   V1_data(n) = V1;53   V2_data(n) = V2;54   V3_data(n) = V3;55   k10_data(n) = k10;56   k12_data(n) = k12;57   k21_data(n) = k21;58   k13_data(n) = k13;59   k31_data(n) = k31;60   ke0_data(n) = ke0;61   
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1   % MPC ccontroller block initialization2   3   % PK Model4   %  Cp = Cp_Schnider(age, wight, height, gender);5   6   % PD Model7   %  Ce = Ce_Schnider(Cp);8   9   % PK model (from "Optimized PID control of depth 10   %                  of hypnosis in anesthesia")11   12   A = [-(k10+k12+k13) k21 k31;13   k12 -k21 0;14   k13 0 -k31];15   16   B = [1 1 ; 0 0 ; 0 0 ];17   18   C = [1/V1 0 0];19   20   D = 0;21   22   Cp = ss(A, B, C, D);23   Cp = setmpcsignals(Cp, 'MV', 1, 'UD', [2])24   25   %[b, a] = ss2tf(A, B, C, D);26   27   %Cp = tf(b, a);28   29   30   % PD model (from "Optimized PID control of depth 31   %                  of hypnosis in anesthesia")32   %Ce = tf(ke0, [1, ke0]) * Cp;33   34   35   % Nb-to-Cp correlation(from "Impact of propofol on MLAEP in children")36   %{According to Fig 8 in "Pharmacokinetic models for propofol—defining and 37   illuminating the devil in the detail", the output of PK, Cp, is in [ug/ml],38   so we don't need to convert the logistic function's units39   %}40   % f(x) = L/(1+m*e^(-k*t)) + c41   42   L = 44;43   k = 0.885344   x0 = 0;45   c = 55;46   m = 440;47   48   % Nb latency-to-Cp49   %f(x) = (-log(L./(x-c)-1)+k*x0)./k; % beware: exclude all elements x<5550   51   tfCe = tf(ke0, [1, ke0]);52   53   54   % according to "Guidelines for Intravenous Dosing"                      55   % Lower constraint MV = 0 mg/kg/min56   % Upper constraint MV = 250 ug/kg/min57   58   59   init_Cp = 4; % Initial plasma concentration of propofol in patient60   global ref_Cp61   ref_Cp = 3; % Reference plasma concentration62   63   %% create MPC controller object with sample time64   mpcCp = mpc(Cp, 10);65   %% specify prediction horizon66   mpcCp.PredictionHorizon = 20;67   %% specify control horizon68   mpcCp.ControlHorizon = 2;69   %% specify nominal values for inputs and outputs70   mpcCp.Model.Nominal.U = 0;71   mpcCp.Model.Nominal.Y = 0;72   %% specify constraints for MV and MV Rate73   mpcCp.MV(1).Min = 0;
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74   mpcCp.MV(1).Max = 0.250.*weight; % 75   %% specify overall adjustment factor applied to weights76   beta = 0.54881;77   %% specify weights78   mpcCp.Weights.MV = 0*beta;79   mpcCp.Weights.MVRate = 0.08/beta;80   mpcCp.Weights.OV = 0.75*beta;81   mpcCp.Weights.ECR = 100000;82   %% specify simulation options83   options = mpcsimopt();84   options.RefLookAhead = 'off';85   options.MDLookAhead = 'off';86   options.Constraints = 'on';87   options.OpenLoop = 'off';88   %% run simulation89   %sim(mpcCp, 21, mpcCp_RefSignal, mpcCp_MDSignal, options);90   91   
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B.5 MPC controller simulation for all 14
patients
Stellenbosch University https://scholar.sun.ac.za
1   % The MPC Automated Simulation2   3   % ***DO YOU WANT TO CLEAR THE LOG?**4   Simulink.sdi.clear5   6   % Initialize the MPC using the average patient from the population in7   % Khunle8   pkpd_model = 'D:\Desktop\Masters from Laptop\MATLAB\Masters\PKPD models\PKPD_Paedfusor.m';9   run(pkpd_model);10   11   mpc_model = 'D:\Desktop\Masters from Laptop\MATLAB\Masters\MPC\MPC.m';12   run(mpc_model);13   14   simulink_model = 'D:\Desktop\Masters from Laptop\MATLAB\Masters\Simulink\Main\MLAEP_simulink_model.slx';15   tic16   sim(simulink_model);17   toc18   19   % Initialize the patient population20   patient_pop = 'D:\Desktop\Masters from Laptop\MATLAB\Masters\PKPD models\paediatric_patients2.m';21   run(patient_pop);22   23   % Run the 14 patients through the system24   n=1;25   while n <= 1426   pkpd_model = 'D:\Desktop\Masters from Laptop\MATLAB\Masters\PKPD models\PKPD_Paedfusor_edits.m';27   run(pkpd_model);28   29   mpc_model = 'D:\Desktop\Masters from Laptop\MATLAB\Masters\MPC\MPC.m';30   run(mpc_model);31   32   simulink_model = 'D:\Desktop\Masters from Laptop\MATLAB\Masters\Simulink\Main\MLAEP_simulink_model.slx';33   tic34   sim(simulink_model);35   toc36   37   n=n+138   end39   
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B.6 PID initialization
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1   % PK-PD-latency2   3   % In the loop:4   % 1: Infusion into patient to get the Cp5   % Optional: Cp-to-Ce6   % 2: Cp to latency conversion 7   8   % In the MPC9   % 1: Convert the latency to Cp10   % 2: Convert the Cp to the necessary infusion rate11   12   13   % In the loop:14   15   % PK Model16   %  Cp = Cp_Schnider(age, wight, height, gender);17   18   % PD Model19   %  Ce = Ce_Schnider(Cp);20   21   % PK model (from "Optimized PID control of depth 22   %                  of hypnosis in anesthesia")23   24   A = [-(k10+k12+k13) k21 k31;25   k12 -k21 0;26   k13 0 -k31];27   28   B = [1; 0; 0];29   30   C = [1/V1 0 0];31   32   D = 0;33   34   [b, a] = ss2tf(A, B, C, D);35   36   Cp = tf(b, a);37   38   39   % PD model (from "Optimized PID control of depth 40   %                  of hypnosis in anesthesia")41   Ce = tf(ke0, [1, ke0]) * Cp;42   43   44   % Nb to Cp conversion (from "Impact of propofol45   %                            on MLAEP in children")46   %{47   According to Fig 8 in "Pharmacokinetic models for propofol—defining and 48   illuminating the devil in the detail", the output of PK, Cp, is in [ug/ml],49   so we don't need to convert the logistic function's units50   %}51   L = 44;52   k = 1.5;53   x0 = 4;54   c = 55;55   56   57   syms f(x)58   % Cp-to-Nb latency59   %f(x) = L/(1+exp(-k*(x-x0)))+c;  60   61   62   % Nb latency-to-Cp63   %f(x) = (-log(L./(x-c)-1)+k*x0)./k; % beware: exclude all elements x<5564   65   tfCe = tf(ke0, [1, ke0]);66   67   opt = pidtuneOptions('DesignFocus','reference-tracking')68   PID_C = pidtune(Cp, 'pid2')
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B.7 PID controller simulation for all 14
patients
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1   % The PID Automated Simulation2   3   % ***DO YOU WANT TO CLEAR THE LOG?**4   Simulink.sdi.clear5   6   % ////////////////////////// FOR USE ON PERSONAL LAPTOP \\\\\\\\\\\\\\\\\\\\\\7   8   % Initialize the MPC using the average patient from the population in9   % Khunle10   pkpd_model = 'C:\Users\TPSetati\Google Drive\Masters from Laptop\MATLAB\Masters\PKPD models\PKPD_Paedfusor.m';11   run(pkpd_model);12   13   controller_parameters = 'C:\Users\TPSetati\Google Drive\Masters from Laptop\MATLAB\Masters\PID\PID.m';14   run(controller_parameters);15   16   simulink_model = 'C:\Users\TPSetati\Google Drive\Masters from Laptop\MATLAB\Masters\Simulink\Main PID\2019\MLAEP_simulink_model_PID.slx';17   tic18   sim(simulink_model);19   toc20   21   % Initialize the patient population22   patient_pop = 'C:\Users\TPSetati\Google Drive\Masters from Laptop\MATLAB\Masters\PKPD models\paediatric_patients.m';23   run(patient_pop);24   25   % Run the 14 patients through the system26   n=1;27   pkpd_model = 'C:\Users\TPSetati\Google Drive\Masters from Laptop\MATLAB\Masters\PKPD models\PKPD_Paedfusor_edits.m';28   29   while n <= 1430   31   run(pkpd_model);32   33   simulink_model = 'C:\Users\TPSetati\Google Drive\Masters from Laptop\MATLAB\Masters\Simulink\Main PID\MLAEP_simulink_model_PID.slx';34   tic35   sim(simulink_model);36   toc37   38   n=n+139   end40   41   
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B.8 Measurement noise simulation
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